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Executive summary 
Background: Modifying dietary sodium intake is a cornerstone of diet advice for lowering blood 
pressure under the assumption that it is protective against cardiovascular disease. Previous 
meta-analyses of normotensive participants have not excluded all studies that recruited 
participants with systolic blood pressure (SBP) >140mmHg, which greatly hinders 
generalization to the wider normotensive population.   
Objectives: The objective of this review was to identify the effectiveness of reducing or 
increasing sodium intake on blood pressure in normotensive participants with systolic blood 
pressure ≤140mmHg. 
Inclusion criteria 
Types of participants: This review considered studies on adult participants (≥ 18 years) with 
SBP ≤140mmHg. Studies in pregnant women or patients prescribed antihypertensive or 
vasoactive medications were excluded. 
Types of interventions: Interventions that quantitatively evaluated dietary sodium intake for 
equal to or greater than 4 weeks duration were considered. Only studies that included two study 
arms comprising of different levels of sodium intake were included. 
Types of outcomes: Studies that reported systolic blood pressure (SBP), diastolic blood 
pressure (DBP), pulse wave velocity (PWV), pulse wave analysis, or flow mediated dilatation 
were considered.  
Types of studies: Experimental study designs including randomized controlled trials and 
non-randomized controlled trials were considered. 
Search strategy: An initial search strategy was conducted on databases MEDLINE and 
CINAHL before an extensive search of all relevant published and grey literature databases, and 
clinical trial registries were searched.  
Methodological quality: Potential papers were assessed for methodological validity using the 
standardised critical appraisal instrument from the Joanna Briggs Institute Meta-Analysis of 
Statistics Assessment and Review Instrument (JBI-MAStARI).  
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Data collection and synthesis: Quantitative data was extracted from papers using the 
standardised data extraction tool from JBI-MAStARI and pooled in statistical meta-analysis. 
Effect sizes were expressed as weighted mean differences and 95% confidence intervals. Meta-
analysis was conducted using a random-effect model, and heterogeneity assessed statistically 
using the standard Chi square test and the I2 index. Sub-group analyses were undertaken on 
studies achieving ≥40mmol versus <40mmol in urinary sodium excretion, studies ≤12 weeks 
and studies with a mean BMI ≥30 versus less than 30. 
Results:  
Five trials were included with a total of 1214 participants. The overall reduction in SBP was -
0.71mmHg (95% CI: -2.62, 1.20, p=0.47); and DBP -0.57mmHg (95% CI: -1.26, 0.12, p=0.10). 
There was no significant change in PWV following reduction of dietary sodium over a four to 
six week period. Sub-group analysis did not find a significant effect of urinary sodium 
excretion, study duration ≤12 weeks or BMI on outcomes, however trend towards a greater 
reduction in blood pressure was observed in those with a higher BMI (MD -2.41, 95%CI -5.72, 
+0.91, p=0.16). 
Conclusions: Blood pressure in normotensive participants was not significantly affected by 
sodium modification, and was controlled to within 1% of baseline values overall and with 
extended study duration. Reducing dietary sodium in normotensive participants may still be of 
importance for cardiovascular risk management, however good quality interventional research 
is limited. 
Implications for Practice: Healthy normotensive populations effectively respond to changes 
in sodium intake by regulating blood pressure. Sodium reduction may still be cardio-protective 
but given the lack of data from intervention studies on the safety and efficacy of very low levels 
of sodium intake (<1500mg/day) in those with normal blood pressure, superfluous sodium 
restriction should be avoided.  
Implications for Research: To better understand true normotensive blood pressure response, 
and the impact of sodium on cardiovascular risk, further intervention studies in subjects with 
SBP ≤130-140mmHg are required. Studies should be at least 1-year in duration and follow up 
participant’s cardiovascular risk and outcomes long term. 
Keywords: Normotensive, normotension, blood pressure, pulse wave analysis, salt, sodium  
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Summary of findings:  
Low sodium compared to High sodium in Normotensive subjects 
Patient or population: Normotensive subjects  
Setting: Community settings (i.e. free living populations) and controlled conditions (e.g. metabolic ward, hospital, study centre)  
Intervention: Low sodium  
Comparison: High sodium  
Outcomes Anticipated absolute effects* (95% CI)  № of 
participants  
(studies)  




Risk with High 
sodium 






follow up: range 
4 weeks to 36 
months  
The mean change 
in systolic blood 
pressure ranged 
from -2.8 to 3.0  
The mean change in systolic 
blood pressure in the 
intervention group was 0.71 
lower (2.62 lower to 1.2 
higher)  
1399 
(5 RCTs)  
⨁⨁⨁⨁ 
HIGH  
Moderate heterogeneity was 
observed. Strict inclusion criteria 
reduced the risk of bias but limited the 








follow up: range 
4 weeks to 36 
months  
The mean change 
in diastolic blood 
pressure ranged 
from -2.4 to +2.4  
The mean change in 
diastolic blood pressure in 
the intervention group was 
0.57 lower (1.26 lower to 
0.12 higher)  
1399 
(5 RCTs)  
⨁⨁⨁⨁ 
HIGH  






follow up: range 
4 weeks to 6 
weeks  
The mean changes 
in pulse wave 
velocity ranged 
from -1.4 to +0.13 
m/s  
The mean changes in pulse 
wave velocity in the 
intervention group was 0.82 
m/s higher (0.7 lower to 2.33 
higher)  
100 
(2 RCTs)  
⨁⨁⨁◯ 
MODERATE  1 2 3 
Low heterogeneity was observed. Few 
published trials and the small sample 
size may have limited the ability of this 
meta-analysis to detect a significant 
change  
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of 
the intervention (and its 95% CI).  
 
CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;  
GRADE Working Group grades of evidence 
High quality: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a 
possibility that it is substantially different 
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect 
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect  
1. Publication bias not detected with searching of clinical trial registries and grey literature 
2. Small sample size 
3. Pooling of data from non-obese and obese subjects 
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Hypertension is a significant risk factor for cardiovascular disease (CVD) and has been identified as the 
leading single risk factor in the global burden of disease1, 2 Hypertension guidelines frequently 
recommend salt reduction as an important simple strategy to reduce high blood pressure.2-4 This 
recommendation is often extended to normotensive individuals as well, particularly those at risk of 
becoming hypertensive.5 However, it has not been conclusively shown that dietary sodium reduction in 
normotensive adults is effective in lowering blood pressure. 
The pressure–natriuresis relationship that was first described by Guyton6 proposes a link between 
dietary sodium intake and renal sodium handling. Specifically, the hypothesis states that in a normal 
individual, consumption of a dietary sodium load will elicit a transient rise in blood pressure that 
stimulates the kidney to excrete sodium. The kidney will excrete excess sodium leading to restoration 
of normal blood pressure. This hypothesis explains how blood pressure is maintained over the longer 
term even though most individuals report day-to-day variation in sodium intake.6, 7 Following this 
hypothesis, intervention studies in normotensive subjects may be expected to observe a small amount 
of variation in blood pressure with changes to dietary sodium intake, but this variation should be small 
enough to be considered clinically irrelevant. Intervention studies examining the effect of dietary sodium 
have reported a range of different responses; from significant changes8, 9 to moderate effects on blood 
pressure, to no effect at all.10-12 Normotensive studies that report blood pressure changes over the 
longer term have previously documented changes in systolic blood pressure (SBP) ranging from -
1mmHg12 to increases of 8.2mmHg.8 This variation may be largely explained by the inclusion of 
participants with SBP >140mmHg in earlier normotensive studies, or the exclusion of subjects with SBP 
<120mmHg.   
We searched Cochrane and JBI libraries, Prospero and Medline and identified three previous 
systematic reviews of blood pressure response to dietary sodium restriction.13-15 Unfortunately we also 
identified a major limitation common to all three reviews14  and those with an element of selection bias, 
from pooled results. Whilst some may argue that normotensive response to sodium is irrelevant, it is 
actually critically important for interpretation of evidence in clinical practice that a baseline response to 
dietary sodium is established. A stronger and more robust analysis of response would also assist in the 
development of future clinical trials and public health recommendations, such as WHO guidance and 
dietary guidelines2, 16. 
If the blood pressure reduction in truly normotensive subjects is indeed clinically irrelevant, as Guytons 
hypothesis suggests it should be, future recommendations for sodium reduction in normotensive 
populations with no other blood pressure risk factors would need to establish other cardiovascular 
benefits, such as effects on other markers of arterial function or a direct reduction in cardiovascular risk. 
Whilst literature does not currently provide sufficient quality evidence to directly link sodium intake with 
mortality in normotensive subjects5, it will be important for future reviews to consider this if large scale 
intervention studies are ever conducted. A number of randomised controlled trials have however 
investigated the effects of dietary sodium intake on arterial function, and found that these effects may 
be at least partly independent of blood pressure.17-22 As these effects may be key in extending our 
understanding of sodium intake and disease risk, they form part of the bigger picture for dietary sodium 
intake and chronic disease risk. It is therefore important to consider data on arterial function such as 
pulse wave analysis, pulse wave velocity and flow mediated dilation in current and future meta-analyses 
of sodium restriction. 
A revised systematic review and meta-analysis of normotensive response to sodium modification is 
required.23 This systematic review will consider the evidence for longer term dietary sodium restriction 
in participants with SBP <140mmHg on arterial function. 
Objectives 
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The objectives are to identify the effect of reducing or increasing sodium intake on blood pressure in 
normotensive adults with SBP ≤140mmHg, and the effect of sodium reduction or supplementation on 
arterial function in participants with baseline SBP ≤140mmHg. 
Inclusion criteria 
Types of participants  
This review considered studies on adult participants with SBP ≤140mmHg conducted in community 
settings (i.e. free living populations) and controlled conditions (e.g. metabolic ward, hospital, study 
centre). Studies in pregnant women or participants prescribed antihypertensive or vasoactive 
medications were excluded. 
Types of interventions 
Interventions that evaluated dietary sodium intake for ≥4 week’s duration were considered. Only studies 
that included two study arms comprising of different levels of sodium intake, and that modified sodium 
intake via dietary modification, salt reduction and/or salt supplementation were included. 
Types of outcomes 
Studies that reported SBP, diastolic blood pressure (DBP), pulse wave velocity, pulse wave analysis, 
or flow mediated dilatation (FMD) by Doppler ultrasound were considered.  
Types of studies 
Experimental study designs including randomized controlled trials and non-randomized controlled 
trials were considered. Studies with an element of selection bias (e.g. normotensive studies that 
excluded subjects with systolic blood pressure <120mmHg) were excluded. 
Search strategy 
The search strategy (Appendix I) endeavoured to find both published and unpublished studies. A three-
step search strategy was utilised in this review. An initial limited search of MEDLINE and CINAHL was 
undertaken followed by analysis of the text words contained in the title and abstract, and of the index 
terms used to describe article. A second search using all identified keywords and index terms was then 
undertaken across all included databases. Thirdly, the reference lists of all identified reports and articles 
were searched for additional studies. Studies published in any language were considered for inclusion 
in this review, with non-English publications translated to English. Titles and/or abstracts published in 
non-English language were translated before decision to include or exclude. Studies published between 
1980 and the present day were considered for inclusion in this review. Prior to 1980, the definition of 
normotension exceeded 160mmHg systole. In addition, such studies were not well controlled or 
reported as per the CONSORT statement.24  
The databases searched included; MEDLINE, CINAHL, PROQUEST, Scopus, EMBASE, Cochrane 
Library, and Wiley InterScience. Additionally clinical trial registrars Australia and New Zealand Clinical 
Trials Registry, ClinicalTrials.gov, ISRCTN, WHOICTRP were searched using the search terms listed 
below. These registries were rechecked prior to manuscript submission to ensure no other recently 
published studies matched the inclusion criteria of this review. The search for unpublished studies 
included: Proquest Dissertations and Theses Database, Dissertations and Theses International, 
Mednar, OpenSIGLE, EAGLE. Initial keywords used were: sodium, salt, blood pressure, normotens*, 
systolic, diastolic, pulse wave, controlled, endothelial function, diabet*. 
Method of the review 
Critical appraisal 
Potential papers selected for retrieval were assessed for methodological validity prior to inclusion using 
the standardised critical appraisal instrument from the Joanna Briggs Institute Meta-Analysis of 
Statistics Assessment and Review Instrument (JBI-MAStARI; Appendix II). The papers retrieved were 
assessed by two reviewers (SK, JK) prior to inclusion in the review using standardised critical appraisal 
instruments from the Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review 
Instrument (JBI-MAStARI) (Appendix II). The JBI_MAStARI tool captured study design limitations and 
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the critical appraisal process also identified elements of selection bias (e.g. studies excluding true 
normotensive participants <120mmHg) and variation within interventions such as the dose, method and 
duration of dietary sodium modification that were evaluated. Where a a study scored poorly on the JBI-
MASTARI tool or a high level of selection bias (eg. exclusion of participants with SBP<120mmHg) or 
significant confounding was identified, studies were excluded from the review. Any disagreements that 
arose between the reviewers were resolved through discussion, or through a third reviewer (KD or AT). 
Where a reviewer had been involved in research work that had resulted in the publication of an included 
study, the respective study was assigned to an alternative reviewer for quality analysis. 
Data collection 
Quantitative data were extracted from papers included in the review using the standardised data 
extraction tool from JBI-MAStARI (see Appendix III). The data were extracted independently by two 
reviewers (JK, SK), and included specific details about the interventions, populations, study methods 
and outcomes of significance to the review question and specific objectives. Any difference in data 
extraction was resolved through discussion, or by a third reviewer (AT). A process reviewer checked 
adherence to study protocol (SH). For studies with missing data, an attempt was made to contact 
corresponding authors in order to make a decision about the studies eligibility and/or to include in our 
analysis. 
Data synthesis 
For each trial retrieved, outcome variables for overall treatment effect were calculated. For crossover 
trials, the calculated treatment effect was the difference between end of reduced sodium period and the 
end of control period from baseline. For parallel trials, the treatment effect was the difference between 
the intervention (i.e. reduced dietary sodium) and control groups change from baseline to the end of 
follow-up for each of the measured outcomes. A correlation coefficient (r) of 0.5 was used to impute the 
missing SD of change.19 The SD of net change for cross-over trials was also imputed using r = 0.5. 
Quantitative data was, where possible, pooled in statistical meta-analysis using RevMan (version 5.3.3). 
All results were subject to double data entry. Due to the variation observed in the characteristic of trials 
included, the DerSimonian and Laird random-effect model was used in conducting the meta-analysis. 
Heterogeneity assessed statistically using the standard Chi square and the I2 index. An I2 value of 25% 
was considered to represent low heterogeneity, and 75% high heterogeneity.25 Values were considered 
statistically different from zero using a Z-test analysis where p < 0.05 was observed. Where statistical 
pooling was not possible the findings were presented in narrative form including tables and figures to 
aid in data presentation where appropriate. A one-by-one sensitivity analysis was performed by 
assessing the effect of individual studies on the overall results of meta-analysis. To assess the 
robustness of chosen correlation coefficient, sensitivity analysis of alternative coefficients (r = 0.2 and 
0.8) was also conducted. Sub-group analyses were planned to examine studies recruiting participants 
with SBP ≤130mmHg, studies achieving a 40mmol or greater reduction in urinary sodium excretion, 
studies conducted in participants of different ethnicities, and studies conducted in those with and without 
a diagnosis of diabetes. We only identified one study each in  participants with SBP ≤130mmHg, 
participants of African American ethnicity, and in participants with diabetes, therefore sub-group 
analysis was not conducted.  
Results 
Number of studies found and retrieved 
The search strategy identified 1724 studies, from which 1491 were excluded on the basis of title and 
abstract review. Upon detailed review, 221 articles were excluded primarily for reasons outlined in the 
PRISMA flow chart (see Figure 1). The most common reasons for exclusion were inclusion of 
participants with baseline systolic blood pressure above >140mmHg, use of antihypertensive 
medications, or study duration less than four weeks (see appendix IV for excluded studies). A total of 
12 studies were initially retrieved but following eligibility assessment a further seven were excluded for 
being outside the inclusion criteria for this review. Two of these studies26, 27 were excluded following 
contact with authors that confirmed both studies had five percent of participants with SBP greater than 
140mmHg at baseline. Two studies28, 29 did not have values for SBP inclusion at baseline and were 
excluded when the authors were unable to provide appropriate statistical data, and one study used a 
25% potassium chloride salt substitute and reported a four-fold greater increase in potassium excretion 
in the intervention group compared with the control group.30 Two further studies31, 32 were excluded, as 
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they only recruited pre-hypertensive participants and excluded participants with SBP <120mmHg. 
These studies were not considered of appropriate design to inform the main objective of this review – 
to establish the effect of modifying dietary sodium intake in normotensive participants, due to the 
significant population of normotensive subjects that were excluded. The exclusion of subjects with 
SBP<120mmHg was considered to introduce a significant element of selection bias that was likely to 
impact the outcome of these studies. Further identification of potential studies was carried out by 
analysing all included studies’ reference lists, and one additional study was retrieved. Following quality 
analysis one further study33 was excluded (Table 1) to give a total of five studies. One non-English study 
was identified as meeting the inclusion criteria,33 this study was available in English format and was 
excluded on quality assessment. One study reported the SD of change from baseline7 however mean 
























Figure 1: Flow-chart for the search and study selection process 
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Of the five articles retrieved and included in the meta-analysis, four were crossover designs,10, 11, 20, 34 
and one was a parallel study design.12  Three studies were in Caucasians,10, 11, 20 one was in a African 
American population,34 and one was mixed race.12 All studies utilised different BMI cut-offs, two included 
obese participants12, 20 and two were in non-obese participants.10, 11 One study did not include BMI as 
an inclusion or exclusion criteria.34 Two studies10, 11 implemented four week duration interventions, one 
implemented a six week intervention,20 another an eight week intervention.34 The longest study ran for 
48 months, with data collected on all participants for a minimum of 36 months.12 All five articles reported 
SBP and DBP, two studies reported PWV,11, 20 and one study reported FMD.20 Physical activity was not 
reported in the five included studies.   
 
Methodological quality 
Methodological quality was moderate-to-high across all included studies (see Table 1). Randomisation 
procedures were adequate in the majority of the included studies and all treatment groups were 
comparable at entry and treated identical throughout the treatment period. Blinding of study personnel 
was only possible in one study, although blinding of the participant was only done in two of the included 
studies, achieving this type of blinding is generally difficult in dietary studies,35 and is reduced by 
ensuring all outcome assessors are blind to the randomisation allocation, which was done adequately 
in four of the five studies.  
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Table 1: Quality assessment of the included studies. 
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 
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Results of the quantitative analysis 
Effects of sodium reduction interventions: 
A total of five trials with eight comparisons encompassed 1214 participants. The characteristics of studies included in this meta-analysis are 
presented in Appendix V. The mean blood pressure in the control/high sodium intake groups was 119.4/76.9mmHg. Estimated sodium excretion on 
usual sodium intake based on 24-hour collections and dietary intervention targets, was 175mmol (10 g/day salt), ranging from 134 to 190mmol (8-
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11g/day salt). The estimated change in dietary sodium from the usual to the reduced salt intake was -75mmol/day (range -37 to -136mmol), 
equivalent to a reduction in sodium intake 4 g/day (range 2-8g/day). 
High sodium versus low sodium for blood pressure in all participants 
Five trials (n=1214) were retrieved with data available for SBP; with a mean difference (MD) of -0.71mmHg (95% CI: -2.62, 1.20). There was no 
significant change in SBP following reduction of dietary sodium over the period of four weeks to 36 months (p=0.48 see Figure 2). The data displayed 




Figure 2: Forest plot of the effect of salt modification on systolic blood pressure. The effectiveness of salt modification is presented 
using random effect. The mean and SD of changes from baseline are reported for trials. Effects of trial are presented as weight (%) and mean 
difference (95% CI). The size of the box and its location on horizontal line represents the weight of each study; the variance reported by each 
study is represented by the horizontal line. 
 
A total of five trials (n=1214) for DBP (Figure 3) had a MD of -0.57 mmHg (95% CI: -1.26, 0.12). There was no significant change in DBP following 
reduction of dietary sodium over the period of four weeks to 36 months (p=0.10). The data had low heterogeneity (Chi2 =3.21, p=0.52; I2=0%). Sensitivity 
analysis excluded individual studies and assessed the effect on overall results of meta-analysis. No significant effect on meta-analysis was observed 
by excluding any study on mean difference of DBP.  
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Figure 3: Forest plot of the effect of salt modification on diastolic blood pressure. The effectiveness of salt modification is presented 
using random effect. The mean and SD of changes from baseline are reported for trials. Effect of trial are presented as weight (%) and mean 
difference (95% CI). The size of the box and its location on horizontal line represents the weight of each study; the variance reported by each 
study is presented by the horizontal line 
 
 
Sub-analysis of four trials with urinary sodium excretion >40mmol/day gave four comparisons encompassing 1102 participants with a MD of -0.40 (95% 
CI: -3.61, 2.81; p=0.81) (Table2). Sub-group analyses were originally planned to examine studies recruiting participants with SBP ≤130mmHg, 
participants of different ethnicities, participants with and without diabetes. Only one study was located that presented data for participants with SBP 
<130mmHg11 and only one study was included, that presented data for participants of African American ethnicity,34 therefore sub-analyses were not 
conducted. No studies were available in participants with diabetes.  
Subgroup analysis of the duration of intervention showed a non-significant reduction of SBP and DBP when intervention duration is ≤12 weeks. The 
subgroup of cross-over design of the study did not show any statistically significant results. We also planned to present between group analyses for 
study design (parallel versus cross-over), and sodium excretion (>40mmol versus <40mmol/24 hours), however only one study was available for 
participants with a sodium reduction of <40mmol/24 hours and only one study was of parallel design. 
Subgroup analysis also explored the sources of heterogeneity observed in meta-analysis results of SBP. A high heterogeneity was observed with 
subgroup of studies with intervention duration ≤12 weeks (74%). This may suggest an influence of study duration on the heterogeneity of results, 
however we are unable to confirm this as  as only one study satisfies the ≥12 week study duration criteria. Baseline BMI of participants did not have a 
statistically significant effect on the meta-analyses of BP. However, a trend was observed with more pronounced reduction of both SBP and DBP in the 
subgroup of participants with mean baseline BMI >=30 kg/m2, compared to those with mean BMI <30 kg/m2 (Table 2).The test for subgroup difference 
was not significant for the effect of baseline BMI on BP. 
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Mean difference (95% CI) of 
DBP, mm Hg 
Test for subgroup 
difference 
Intervention duration 
≤ 12 weeks 
n=4 -0.24 (-3.62, 3.13; ρ=0.89; I2=64%) 
 
 -0.48 (-1.83, 0.86; ρ=0.95; I2=6%)  
Baseline BMI ≥30 
kg/m2 
n=2 -2.41 (-5.72, 0.91; ρ=0.16; I2= 55%) I2=51%, ρ=0.15 -0.72 (-1.51, 0.07; ρ=0.07; I2= 0%) I2=0%, ρ=0.45 
Baseline BMI <30 
kg/m2 
n=3 -0.71 (-2.62, 1.20; ρ=0.55; I2= 54%)  -0.09 (-1.51, 1.34; ρ=0.91; I2= 0%)  
Reduction in sodium 
excretion ≥ 40 
mmol/24 hours 
n=4 -0.40 (-3.61, 2.81; ρ=0.81; I2=66%) 
 
 -0.55 [-1.14, 0.03; ρ=0.71; I2=6%) 
 
 
Design (Cross-over) n=4 -0.24 (-3.62, 3.13; ρ=0.89; I2=64%)  -0.48 (-1.83, 0.86; ρ=0.48; I2=6%)  
All trials (meta-
analysis result) 
n=5 -0.71 (-2.62, 1.20; ρ=0.47; I2=54%)  -0.57 (-1.26, 0.12; ρ=0.10; I2=0%)  
1- Abbreviations used in this table: DBP: Diastolic blood pressure; SBP: Systolic blood pressure, BMI: Body-mass index 
2- Changes in systolic and diastolic blood pressure are presented as mean difference and 95% confidence interval. Heterogeneity (I2) is presented 
by %.  A p-value <0.05 is considered significant.  
High sodium versus low sodium for PWV in all participants 
Of two trials, with two comparisons for PWV (Figure 4), 48 participants had a MD of 82 m/s (95% CI -1.26, 0.12). There was no significant change in 
PWV following reduction of dietary sodium over the period of four to six weeks (p=0.29). We were unable to perform a meta-analysis on FMD, because 
not enough studies met inclusion criteria. 
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Figure 4: Forest plot of the effect of sodium modification on pulse wave velocity. The effectiveness of sodium modification is 
presented using random effect. The mean and SD of changes from baseline are reported for trials. The effect of each trial is presented as 
weight (%) and mean difference (95% CI). The size of the box and its location on horizontal line represents the weight of each study. The 




The sensitivity analysis of individual studies showed a significant effect of one study on SBP10. This may be due to 19 of the 25 participants in this 
study being classified as salt-resistant prior to study commencement, reducing the likelihood of a blood pressure response to dietary sodium. 
Excluding this study showed a more pronounced effect of dietary modification on overall meta-analysis results (-1.34, 95% CI: -2.46, -0.22, p=0.02). 
However, no significant effect of individual studies was observed on DBP. Sensitivity analysis of alternative correlation coefficients (r = 0.2 and 0.8) 
also did not report any significant changes using different levels of correlation coefficient. These results suggest the robustness of the analysis using 
chosen correlation coefficient (r = 0.05) (Appendix VI). 
JBI Database of Systematic Reviews & Implementation Reports 
Page | 14  
This is a non-final, peer reviewed version of an article published in final form in: 
Kelly, J., Khalesi, S., Dickinson, K., Hines, S., Coombes, J. S., & Todd, A. S. (2016). The effect of dietary sodium modification on blood pressure in adults with 
systolic blood pressure less than 140 mmHg: A systematic review. JBI Database of Systematic Reviews and Implementation Reports, 14(6), 196-237. 
https://doi.org/10.11124/JBISRIR-2016-002410 
Discussion 
As far as we are aware, this is the first meta-analysis to report the effects of reducing dietary sodium 
intake on blood pressure as-well as FMD and PWV as markers of arterial function in normotensive 
participants with SBP equal to or less than 140mmHg; consistent with the current definition of 
normotension.36, 37 The finding of this analysis is a reduction following long term sodium modification of 
just 0.6% of the participants’ baseline SBP. This small change in blood pressure is not clinically 
significant, and indicates that modifying sodium intake in truly normotensive individuals is unlikely to 
produce a blood pressure benefit. Reduction in sodium intake in those who are high consumers, or 
those who are pre-hypertensive, or of African American descent may however curb age related rises in 
blood pressure and help to stem cardiovascular risk independent of blood pressure response.  
The lack of blood pressure response to sodium modification in this combined sample of normotensive 
subjects is consistent with Guyton’s hypothesis. This hypothesis provides an explanation for the truly 
normotensive kidney regulating blood pressure in a setting of dietary sodium loading or modification. 
Theoretically, acute phases of sodium loading or reduction should cause transient rises or falls in blood 
pressure, which are corrected by the normal functioning kidney after an initial period between one to 
two weeks.7 Blood pressure appears to have been effectively regulated by the kidney in the majority of 
subjects in this review and a marked increase in blood pressure was not sustained. Although the pooled 
results show little effect of sodium, it is worth noting that the five included studies varied in their findings, 
reporting a range of changes to SBP from -5mmHg20 to +3.7mmHg.10 This variation can likely be 
attributed to participant characteristics. Close examination of the methods of the studies included in this 
analysis indicate that differences in SBP response may be due to factors such as the presence of 
obesity,12, 20 or inclusion of participants of African-American ethnicity.34  
To test the robustness of our primary finding, we performed sub-analyses by intervention duration less 
than 12 weeks and studies achieving greater (verse less) than 40mmol/day sodium reduction. Both 
these subgroups had similar non-significant effects on SBP, robust to our primary finding, and thus 
consistent with Guyton’s hypothesis.  
Differences between the results of this meta-analysis and previous meta-analyses can be explained by 
the inclusion of studies. Previous meta-analyses included all studies on participants ‘labelled’ as 
normotensive, including those conducted over 20 years ago when the definition of high blood pressure 
was undergoing review. Many trials labelled as normotensive trials were conducted prior to 1993,26, 38-
42 and the range of blood pressure readings observed in these trials is greater than the range of blood 
pressure readings observed in more recent studies of normotensive participants.10, 20 Excluding early 
studies that include participants with SBP >140mmHg is necessary in order to detect the true effect of 
sodium reduction in participants with normal or high normal blood pressure.10 However, exclusion of 
these studies greatly limits the field of available literature that has previously been described in 
numerous reviews. We initially planned to include sub-analysis of studies in normotensive participants 
with absence of pre-hypertension (i.e. SBP <130mmHg), in black populations, and in diabetics; but too 
few studies were retrieved to enable this.  
The inclusion of pre-hypertensive participants in some studies included in this analysis may also 
account for some of the heterogeneity, as pre-hypertensive participants have previously been shown 
to have a greater response to sodium than their normotensive counterparts.  It is worth noting that the 
DASH-Sodium study31 was not included in this meta-analysis as it excluded the main population of 
interest- those with truly normotensive blood pressure (systolic blood pressure <120mmHg) and ran the 
intervention concurrently with other dietary changes that significantly altered potassium excretion. This 
study examined pre-hypertensive participants (SBP 120-140mmHg) and hypertensive participants. A 
reduction in sodium intake of 77mmol was observed in both the US diet arm and the DASH diet arm 
and the mean blood pressure on the US diet with high sodium intake was 128/81mmHg and this reduced 
by -5.6/-2.8mmHg following the low sodium intervention, in the pre-hypertensive subgroup. 
Urine sub-analysis 
A modest sodium reduction of 30mmol/24 hour has been proven in controlled and free-living situations 
to elicit a blood pressure response at a significant level.12, 32, 42, 43 Previous trials have only included 
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studies that had a 24-hour sodium urine excretion of >40mmol/day. For consistency with other literature 
we performed a sub-analysis of trials that achieved a urinary sodium reduction of 40mmol/day was 
performed and resulted in a non-significant reduction in SBP of -0.40 (95% CI: -3.61, 2.81; p=0.81) (see 
Table 2). It appears that regardless of the dose of sodium reduction, the normotensive kidney is effective 
in regulating blood pressure, robust to the primary finding.  
Twenty-four hour urine collections to measure sodium excretion are the most accurate marker of dietary 
sodium intake in both epidemiological and experimental studies of dietary sodium restriction. However, 
compliance with complete collections is difficult to achieve in participants.14 Two studies11, 34 did not 
measure 24 hour urinary sodium excretion and were not included in this sub-analysis as a result. In 
Todd et al.,11 ongoing dietetic review in all interventions in addition to regular early morning spot urine 
tests were used in place of 24 hour urinary sodium excretion to ensure dietary compliance to the 
interventions. The other study by Flack et al.34 utilised a pooled 24 hour urinary (three individual eight 
hour collections) in addition to sodium pill counts in both interventions. These methods, although not 
the gold standard, have been shown to elicit significant differences in sodium excretion,19 and have a 
role in measuring compliance, while ensuring the relevance in a clinical setting and reducing burden to 
participants in longer term studies. Both trials detail interventions that would have placed considerable 
burden on participants, through the complex nature of their design and lengthy durations, of 18 and 26 
weeks respectively.   
PWV and FMD Sub-analyses 
PWV reflects artery elasticity - the higher the velocity of pulse wave transmission, the less elastic the 
wall.44 Studies to date in normotensive participants have not yielded significant results in participants 
with SBP <140mmHg.11, 20, 21 Improvements previously reported have been conducted in populations 
with blood pressure ranges up to 160mmHg.45 FMD has been shown to be impaired following sodium 
loading in two previous normotensive studies, the included study by Dickinson et al.20, 21 These studies 
both document non- significant correlations between FMD and blood pressure20, 21 and only moderate 
correlations to PWV in hypertensive participants (r = 0.52, P<0.05);19 suggestive of blood pressure 
independent pathways to endothelial and arterial function.  
Relevance of the findings 
Despite the World Health Organisation and other government bodies reporting that sodium reduction 
can reduce blood pressure in normotensive individuals,2, 16 this is not supported by the current available 
evidence. Previous analyses of data used to inform public health policy around sodium intake have not 
acknowledged the limitations of available randomised controlled trials, and have incorrectly included 
studies with hypertensive participants in normotensive analyses. This has resulted in a greater blood 
pressure lowering effect than that which actually exists in truly normotensive individuals. 
The results of this meta-analysis clearly demonstrates that modifying dietary sodium in healthy 
normotensive populations is not clinically effective to reduce blood pressure at an individual level over 
a period of four months to one year. Blood pressure remained within 1% of the subjects baseline 
readings, and only two studies were included in this subgroup which makes it difficult to draw conclusion 
on the influence of higher duration of modification. Reducing blood pressure is only of significance if it 
results in a reduction in CVD,46, 47 and it has been previously suggested that this does not occur until a 
sustained change of 2-3mmHg over the long term is achieved.47 
Despite the lack of effect on blood pressure it is important to note that reducing sodium may still be 
important in normotensive participants at a population level, as it may help to reduce the age-related 
rise in blood pressure and cardiovascular risk.46, 48-51 Although there is good evidence to suggest 
reduction of sodium intake from high to moderate levels is safe and may benefit public health, recent 
epidemiological studies have controversially reported an increased CVD risk at very low levels of 
sodium intake (<1500mg/day).52-54 This J-shaped association has predominantly been noted in 
diabetics and those with pre-existing heart disease.52, 54  Recent data from the NHANES study indicates 
intakes greater than 1500mg sodium per day are likely to be safe for the majority of the population,55 
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and this is in line with the magnitude of sodium reduction used in the majority of studies included in this 
review. 
It is worth noting that separate meta-analyses addressing questions around cardiovascular risk 
reduction and sodium intake are available, but none contain a non-confounded analysis of normotensive 
participants. Taylor and co-workers,56 included two trials in the normotensive analysis that recruited 
individuals with SBP >140mmHg26, 42 in their meta-analysis of longer term RCT’s examining overall 
mortality, cardiovascular mortality and cardiovascular morbidity. Only three truly normotensive trials 
were included and no findings were presented for overall or cardiovascular mortality, however a 
reduction in cardiovascular events was reported (RR 0.71, 95% CI 0.42, 1.20 p=). A second meta-
analysis by Strazzullo et al.51 also included both normotensive and hypertensive participants in a meta-
analysis that evaluated dietary sodium intake and cardiovascular events. An increased risk of stroke 
(RR 1.23, 95% CI1.06, 1.43 p=0.007) and a non-significant trend between dietary sodium and CVD (RR 
1.14, 95% CI 0.99, 1.32, p=0.07) was observed, however as with the meta-analysis by Taylor and co-
workers it is impossible to determine from this analysis if an increased risk of CVD or stroke would be 
present in a purely normotensive population with SBP ≤140mmHg.  
Cardiovascular risk associated with dietary sodium intake is an area in which further long term research 
is required. In our meta-analysis, four of the five studies included were less than eight weeks duration,10, 
11, 20, 34 and only one trial had a duration greater than a year.12 In the context of cardiovascular risk, even 
trials labelled as long term are too short (i.e. less than six months) to measure outcomes in terms of 
cardiovascular events.  
Potential limitations of this systematic review 
A limitation of this study, like previous meta-analyses, is the lack of longer term trials with large sample 
numbers. We excluded studies that did not exclude all participants with hypertension as per the 
definition set by the JNC-7, and supported by the panel members of JNC-8.36, 37 This resulted in two 
long term multi-centre trials being excluded.26, 42 These two studies recruited a combined total of 1308 
participants assigned to either a sodium reduction or control group, however, five percent of participants 
had SBP greater than 140mmHg.47, 48 The long term effects of these sodium reduction interventions26, 
42 were -1.69/0.85mmHg and -0.3/0.1mmHg, respectively. Another limitation centres on retrieving the 
appropriate statistical information for dated and large scale multicentre trials. Because we could not be 
provided with such detail in some instances, trials were excluded.32 One trial which had data for 
subgroups of normotensive populations31 could not be included because the statistical data concerning 
mean and standard deviation for SBP/DBP could not be sourced. 
Differences Between the Protocol and the Review 
Additional exclusion criteria were added to ensure the results of the meta-analysis were consistent with 
the purpose of the review. Trials in pregnant women and trials that intentionally excluded truly 
normotensive subjects were excluded. JBI MAStARI was originally specified as the pooling software for 
the meta-analysis, as reported in our protocol,23 however MAStARI was not operational at the time, so 
the review authors elected to use RevMan 5.3.5 consequently  to conduct the meta-analysis. Additional 
sub-analyses were conducted for BMI and study duration, as these were additional study design 
aspects identified as having the potential to influence outcomes. 
Implications for Public Health 
• Current public health recommendations for reducing cardiovascular disease emphasise importance 
of population sodium reduction as a strategy to reduce blood pressure. The studies included in this 
review suggest modifying dietary sodium in a seemingly healthy normotensive population is not 
clinically effective to reduce blood pressure over a period of four months to one year at an individual 
level (JBI Grade B evidence); 
• High sodium intake is linked to a higher risk of stroke, left ventricular hypertrophy, renal impairment, 
and can impair the arterial vasculature and endothelial function.15, 18, 19, 22, 57 A moderate reduction 
in dietary sodium, to achieve a sodium intake  between 1500-2300mg per day, may be cardio-
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protective independent of the blood pressure pathway; but this is inconclusive. It also may not be 
safe to recommend sodium restriction in older adults with diabetes or those with established 
cardiovascular disease. (JBI Grade B evidence). 
• Given the lack of data on very low levels of sodium intake (<1500mg/day) in the general population, 
sodium restriction below this level should not be routinely recommended. (JBI Grade B evidence). 
Implications for future research 
Further long term clinical trials in normotensive subgroups are warranted to examine the effects of 
ethnicity, obesity, pre-hypertension, and diabetes. Recent literature suggests blood pressure reduction 
should not be overzealous in participants with diabetes,52, 58 and individuals with hypertension and 
diabetes should be treated to a minimum blood pressure of 130mmHg,59, 60 however this should be 
confirmed by well-designed randomised controlled clinical trials. As it is currently unknown what level 
of sodium reduction is safe for normotensive diabetics, trials should initially err on the side of caution 
and restrict sodium to a minimum intake of 1500mg/day. Dietary sodium restriction also has the potential 
to exacerbate glucose intolerance, therefore this outcome should be simultaneously examined, along 
with effects on the renin-angiotensin-aldosterone system. 
To better understand dietary sodium intake, true normotensive blood pressure response, and the impact 
on CVD risk, studies that examine dietary sodium, blood pressure response and cardiovascular risk in 
participants with SBP equal to or less than 140mmHg over the longer term (i.e. greater than one year) 
are required. Randomised controlled trials with long term (greater than four week) duration should also 
be undertaken to look at other surrogate markers of cardiovascular risk, especially in the absence of 
longer term clinical trials examining hard outcome measures, which are likely to be logistically difficult, 
lengthy and very costly to undertake.61  
Conclusions 
Normotensive participants seemingly free of any renal or cardiovascular impairment are efficient in 
effectively regulating blood pressure to within 1% of their baseline SBP values, following a sodium 
reduction intervention. Blood pressure alone may not be effectively lowered by reducing dietary sodium 
in normotensive participants, however reducing cardiovascular disease risk may still be of importance.  
This review confirms that the blood pressure response of normotensive participants with systolic blood 
pressure less than or equal to 140mmHg does not significantly change over a period of four weeks or 
more. 
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Appendix I: Search strategy 
 
MEDLINE (via Pubmed) 
The following key words were used (03/03/2014) in the combination  
Search  Query 




#3 1 OR 2  
 
#4 normotens*  
 




#7 4 OR 5 OR 6 
 
#8 blood pressure  
 
#9 pulse wave  
 
#10 endothelial function 
 
#11 flow mediated 
 




#14 3 AND 7 AND 12 AND 13 
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Appendix II  
MAStARI Appraisal instrumentmessage 
this is a ert page break 
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Appendix III 
MAStARI data extraction instrument 
 
Insert page break 
Insert page break 
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Appendix IV: Table of included studies 
Table 3: Table of included studies 
MAStARI 










Free living  





Controlled 6g/day salt 
diet (+ placebo tablets) 
Controlled 6g/day salt 




3. FMD  
4. PWV, PWA,  


















8. Dietary intake  
Sample comprised of obese/o  
participants 
Flack RCT X United N= 112: Native 10 individualised dietary 10 individualised dietary 1. BP Participants only included if the   
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counselling sessions + 1-
2 if required – aimed for 
a target sodium intake of 
75-80mmol/day + sodium 
tablets 
counselling sessions + 
1-2 if required – aimed 
for a target sodium 
intake of 75-
80mmol/day + placebo 
tablets 
2. Weight 
3. Urinary Na+, K+, 
Cr 
4. Plasma Na+, K+, 
Cr, glucose, 
5. Dietary intake 
<140mmol/day in the eligibil   
 
Compliance to intervention th   










Free living , 
studied in 
hospital last 
day of each 
intervention  
N= 25 (6 salt 
sensitive, 19 salt 
resistant), Male 
and female aged 




85mmol sodium for four 
weeks  
Standardised diet 
200mmol sodium for 
four weeks 
1. BP 
2. Plasma Na+, K+  
3. Lipid profiles 






Salt resistant individuals do not  
great falls in blood pressure follo   
reduction, compared to salt se    
sample is unevenly represen    











Free living  
N= 23: Male and 
female aged 20-








Low salt (60mmol/day) 
diet consumed by all 
participants – in addition 
consuming a high salt 
(200-250mmol Na) 
tomato juice for 4 weeks. 
Low salt (60mmol/day) 
diet consumed by all 
participants – in 
addition consuming a 
no added salt tomato 




3. PWV, PWA,  









Compliance to intervention th   
histories and spot urine an  
 
4 participants dropped out, only   
the high salt interventi  
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reduction – n= 
515 
Control – n= 514 





BP <139/89, no 
clinical 
Sodium reduction group 
(target 80mmol/day)  




3. Urinary Na+, K+, 
Cr 
4. Dietary intake Large blood pressure changes w   
in initial 6 months. Over 36 m   
changes were less prono   
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Appendix V: Excluded studies 
Adeyemo AA, Prewitt TE, Luke A, Omotade OO, Rotimi CN, Brieger WR, et al. The feasibility of 
 implementing a dietary sodium reduction intervention among free-living normotensive 
 individuals in south west Nigeria. Ethnicity & disease. 2002;12(2):207-12.  
  Reason for exlcusion: Recruited above 140mmHg (<160mmHg) 
Allen AR, Gullixson LR, Wolhart SC, Kost SL, Schroeder DR, Eisenach JH. Dietary sodium influences 
 the effect of mental stress on heart rate variability: a randomized trial in healthy adults. J 
 Hypertens. 2014;32(2):374-82. 
  Reason for exclusion: Study duration less than 4 weeks 
Aro A, Pietinen P, Valsta LM, Salminen I, Turpeinen AM, Virtanen M, et al. Lack of effect on blood 
 pressure by low fat diets with different fatty acid compositions. J Hum Hypertens. 
 1998;12(6):383-9. 
  Reason for exclusion: No intervention of interest 
Australian National Health & Medical Research Council Dietary Salt Study Management Committee.  
Fall in blood pressure with modest reduction in dietary salt intake in mild  hypertension. 
Lancet. 1989;1(8635):399-402.     
Reason for exclusion: Studies on hypertensives 
Australian National Health & Medical Research Council Dietary Salt Study Management Committee.  
Effects of replacing sodium intake in subjects on a low sodium diet: a crossover  study. Clin 
Exp Hypertens. 1989;11(5-6):1011-24. 
Reason for exclusion: Recruited above 140mmHg 
 
Azizi M, Linhart A, Alexander J, Goldberg A, Menten J, Sweet C, et al. Pilot study of combined 
 blockade of the renin-angiotensin system in essential hypertensive patients. J Hypertens. 
 2000;18(8):1139-47. 
  Reason for exclusion: Studies on hypertensives 
Barba G, Vallance PJ, Strazzullo P, MacAllister RJ. Effects of sodium intake on the pressor and renal 
 responses to nitric oxide synthesis inhibition in normotensive individuals with   
 different sodium sensitivity. J Hypertens. 2000;18(5):615-21. 
  Reason for exclusion: Study duration less than 4 weeks 
Barri YM, Wilcox CS. Salt intake determines the renal response to L-arginine infusion in normal 
 human subjects. Kidney Int. 1998;53(5):1299-304. 
  Reason for exclusion: Study duration less than 4 weeks 
Beerendonk CC, Derkx FH, Schellekens AP, Hop WC, van Dop PA. The influence of dietary sodium 
 restriction on renal and ovarian renin and prorenin production during ovarian stimulation. 
 Hum Reprod. 1996;11(5):956-61. 
  Reason for exclusion: Study groups not comparable - low sodium group started   
 intervention 10 days before control group. 
Benetos A, Xiao YY, Cuche JL, Hannaert P, Safar M. Arterial effects of salt restriction in 
 hypertensive patients. A 9-week, randomized, double-blind, crossover study. J Hypertens. 
 1992;10(4):355-60. 
  Reason for exclusion: Studies on hypertensives 
Blumenthal JA, Babyak MA, Hinderliter A, Watkins LL, Craighead L, Lin PH, et al. Effects of the 
 DASH diet alone and in combination with exercise and weight loss on blood pressure and 
 cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. 
 Arch Intern Med. 2010;170(2):126-35. 
  Reason for exclusion: Recruited above 140mmHg (<159mmHg) 
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Bompiani GD, Cerasola G, Morici ML, Condorelli M, Trimarco B, De Luca N, et al. Effects of moderate 
 low sodium/high potassium diet on essential hypertension: results of a comparative study. 
 Int J Clin Pharmacol Ther Toxicol. 1988;26(3):129-32. 
  Reason for exclusion: Studies on hypertensives 
Bray GA, Vollmer WM, Sacks FM, Obarzanek E, Svetkey LP, & Appel LJ. A further subgroup analysis  
of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of 
the DASH-Sodium Trial. Am J Cardiol, 2004; 94(2): 222-227. 
Reason for exclusion: Population not considered suitable for the assessment of the primary 
 outcome as subjects with SBP <120mmHg were excluded. Pre-hypertensive subjects display 
 a heightened response to sodium.  
 
Brier ME, Luft FC. Sodium kinetics in white and black normotensive subjects: possible relevance to 
 salt-sensitive hypertension. Am J Med Sci. 1994;307(Suppl 1):S38-42. 
  Reason for exclusion: Study duration less than 4 weeks 
Buckley MG, Markandu ND, Sagnella GA, MacGregor GA. Brain and atrial natriuretic peptides: a dual 
 peptide system of potential importance in sodium balance and blood pressure regulation in 
 patients with essential hypertension. J Hypertens. 1994;12(7):809-13. 
  Reason for exclusion: No Sodium intervention; Study duration less than 4 weeks 
Bunke M, Gleason JR, Jr., Brier M, Sloan R. Effect of erythropoietin on renal excretion of a sodium 
 load. Clin Pharmacol Ther. 1994;55(5):563-8.    
  Reason for exclusion: No intervention of interest 
Butscher K, Jamali S, Talib R, Ravussin P, Poggi-Bach J, Ecoffey C. [Effects of different loading 
 solutions on plasma osmolality]. Annales francaises d'anesthesie et de reanimation. 
 1996;15(7):1037-40. 
  Reason for exclusion: No intervention of interest 
Calabrese EJ, Tuthill RW. The Massachusetts Blood Pressure Study, Part 3. Experimental reduction 
 of sodium in drinking water: effects on blood pressure. Toxicol Ind Health. 
 1985;1(1):19-34. 
  Reason for exclusion: Studies in paediatrics  
Capaldo B, Guardasole V, Pardo F, Matarazzo M, Di Rella F, Numis F, et al. Abnormal vascular  
 reactivity in growth hormone deficiency. Circulation. 2001;103(4):520-4. 
  Reason for exclusion: No intervention of interest 
Cappuccio FP, Kerry SM, Micah FB, Plange-Rhule J, Eastwood JB. A community programme to 
 reduce  salt intake and blood pressure in Ghana. BMC Public Health. 2006;6(1):13. 
  Reason for exclusion: No intervention of interest 
Cappuccio FP, Markandu ND, Beynon GW, Shore AC, MacGregor GA. Effect of increasing calcium 
 intake on urinary sodium excretion in normotensive subjects. Clin Sci. 1986;71(4):453-6. 
  Reason for exclusion: Recruited above 140mmHg 
Cappuccio FP, Markandu ND, Carney C, Sagnella GA, MacGregor GA. Double-blind randomised trial 
 of modest salt restriction in older people. Lancet. 1997;350(9081):850-4. 
  Reason for exclusion: Studies included on hypertensives 
Carney SL, Gillies AH, Smith AJ, Smitham S. Increased dietary sodium chloride in patients treated 
 with antihypertensive drugs. Clin Exp Hypertens. 1991;13(3):401-7. 
  Reason for exclusion: Studies included on hypertensives 
Chalmers J, Morgan T, Doyle A, Dickson B, Hopper J, Mathews J, et al. Australian National Health 
 and Medical Research Council dietary salt study in mild hypertension. J Hypertens. 1986 
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 Dec;4(6):S629-37. 
  Reason for exclusion: Studies included on hypertensives 
Chin-Dusting JP, Alexander CT, Arnold PJ, Hodgson WC, Lux AS, Jennings GL. Effects of in vivo and 
 in vitro L-arginine supplementation on healthy human vessels. Journal of cardiovascular 
 pharmacology. 1996;28(1):158-66. 
  Reason for exclusion: No intervention of interest 
Chopra A, Kumar V, Dutta A. Hypertonic versus normal saline as initial fluid bolus in pediatric septic 
 shock. Indian journal of pediatrics. 2011;78(7):833-7. 
  Reason for exclusion: Studies in paediatrics 
Closas J, Genest J, Larochelle P, Cusson J, Gutkowska J, Hamet P, et al. [Effects of phenylephrine 
 on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential 
 hypertensive patients]. Archives des maladies du coeur et des vaisseaux. 1988;81:75-8. 
  Reason for exclusion: No Sodium intervention; Blood pressure not measured 
Conlin PR. The dietary approaches to stop hypertension (DASH) clinical trial: implications for lifestyle 
 modifications in the treatment of hypertensive patients. Cardiology in Review. 1999;7(5):284-
 8. 
  Reason for exclusion: Reanalysis study 
Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH. Implications of small reductions in 
 diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155(7):701-9. 
  Reason for exclusion: Observational Study 
Cooper JN, Tepper P, Barinas-Mitchell E, Woodard GA, Sutton-Tyrrell K. Serum aldosterone is 
 associated with inflammation and aortic stiffness in normotensive overweight and obese 
 young adults. Clin Exp Hypertens. 2012;34(1):63-70. 
  Reason for exclusion: Not an RCT (Cross sectional) 
Cooper R, Van Horn L, Liu K, Trevisan M, Nanas S, Ueshima H, et al. A randomized trial on the effect 
 of decreased dietary sodium intake on blood pressure in adolescents. J Hypertens. 1984 
 Aug;2(4):361-6. 
  Reason for exclusion: Study on adolescents (24 day study) 
Costa FV, Ambrosioni E, Montebugnoli L, Paccaloni L, Vasconi L, Magnani B. Effects of a low-salt 
 diet and of acute salt loading on blood pressure and intralymphocytic sodium concentration in 
 young subjects with borderline hypertension. Clin Sci. 1981;61 Suppl 7:21s-3s. 
  Reason for exclusion: Studies on hypertensives 
Creager MA, Roddy MA, Holland KM, Hirsch AT, Dzau VJ. Sodium depresses arterial baroreceptor 
 reflex function in normotensive humans. Hypertension. 1991;17(6 Pt 2):989-96. 
  Reason for exclusion: Study duration less than 4 weeks 
Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesey JH. Effect of physiological levels of atrial 
 natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone 
 secretion and renin release in normal man. J Clin Endocrinol Metab. 1987;65(4):765-72. 
  Reason for exclusion: Concomitant venous infusion 
Damasceno A, Caupers P, Santos A, Lobo E, Sevene E, Bicho M, et al. Influence of salt intake on the 
 daytime-nighttime blood pressure variation in normotensive and hypertensive black 
 subjects. Revista portuguesa de cardiologia. 2000;19(3):315-29. 
  Reason for exclusion: Study duration less than 4 weeks 
Damasceno A, Santos A, Pestana M, Serrao P, Caupers P, Soares-da-Silva P, et al. Acute 
 hypotensive,natriuretic, and hormonal effects of nifedipine in salt-sensitive and salt-resistant 
 black normotensive and hypertensive subjects. J Cardiovasc Pharmacol. 1999;34(3):346-53. 
  Reason for exclusion: Study duration less than 4 weeks 
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Damasceno A, Santos A, Serrao P, Caupers P, Soares-da-Silva P, Polonia J. Deficiency of renal 
 dopaminergic-dependent natriuretic response to acute sodium load in black salt-sensitive 
 subjects in contrast to salt-resistant subjects. J Hypertens. 1999;17(12 Pt 2):1995-2001. 
  Reason for exclusion: Study duration less than 4 weeks 
Del Rio A, Rodriguez-Villamil JL. Metabolic effects of strict salt restriction in essential hypertensive 
 patients. J Intern Med. 1993;233(5):409-14. 
  Reason for exclusion: Not an RCT (Cross sectional) 
Diaz KM, Muntner P, Levitan EB, Brown MD, Babbitt DM, Shimbo D. The effects of weight loss and 
 salt reduction on visit-to-visit blood pressure variability: results from a multicenter  randomized 
 controlled trial. J Hypertens. 2014;32(12):840-848. 
  Reason for exclusion: Studies on hypertensives 
Dickinson KM, Clifton PM, Burrell LM, Barrett PH, Keogh JB. Postprandial effects of a high salt meal 
 on serum sodium, arterial stiffness, markers of nitric oxide production and markers of 
 endothelial function. Atherosclerosis. 2014;232(1):211-6. 
  Reason for exclusion: Reanalysis Study (of TOHP II) 
Dickinson KM, Keogh JB, Clifton PM. Effects of a low-salt diet on flow-mediated dilatation in humans. 
 Am J Clin Nutr. 2009;89(2):485-90. 
  Reason for exclusion: Study duration less than 4 weeks 
Dishy V, Sofowora GG, Imamura H, Nishimi Y, Xie HG, Wood AJ, et al. Nitric oxide production 
 decreases after salt loading but is not related to blood pressure changes or nitric oxide-
 mediated vascular responses. J Hypertens. 2003;21(1):153-7. 
  Reason for exclusion: Study duration less than 4 weeks 
Dodson PM, Stephenson J, Dodson LJ, Kurnik D, Kritzinger EE, Taylor KG, et al. Randomised blind 
 controlled trial of a high fibre, low fat and low sodium dietary regimen in mild essential 
 hypertension. J Hum Hypertens. 1989;3(3):197-202. 
  Reason for exclusion: Studies on hypertensives 
Dorough AE, Winett RA, Anderson ES, Davy BM, Martin EC, & Hedrick V. DASH to wellness: 
 Emphasizing self-regulation through E-health in adults with prehypertension. Health Psychol,  
2014:33(3):249-254.  
Reason for exclusion: Concomitant intervention  
 
Duarte JD, Zineh I, Burkley B, Gong Y, Langaee TY, Turner ST, et al. Effects of genetic variation in 
 H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response 
 to hydrochlorothiazide. J Transl Med. 2012;10:56. 
  Reason for exclusion: Studies on hypertensives 
Fagerberg B, Andersson OK, Isaksson B, Bjorntorp P. Blood pressure control during weight reduction 
 in obese hypertensive men: separate effects of sodium and energy restriction. BMJ. 
 1984;288(6410):11-4. 
  Reason for exclusion: Studies on hypertensives 
 
Farquharson CA, Struthers AD. Aldosterone induces acute endothelial dysfunction in vivo in humans: 
 evidence for an aldosterone-induced vasculopathy. Clin Sci. 2002;103(4):425-31. 
  Reason for exclusion: No intervention of interest  
Fauvel JP, Najem R, Ryon B, Ducher M, Laville M. Effects of rilmenidine on stress-induced peak 
 blood pressure and renal function. J Cardiovasc Pharmacol. 1999;34(1):41-5. 
  Reason for exclusion: No intervention of interest 
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Feldman RD, Logan AG, Schmidt ND. Dietary salt restriction increases vascular insulin resistance. 
 Clin Pharmacol Ther. 1996;60(4):444-51. 
  Reason for exclusion: Study duration less than 4 weeks 
Ferrari P, Gadient G, Cozzio A, Shaw S, Weidmann P. Reduced plasma cyclic GMP but normal renal 
 responses to atrial natriuretic factor in pre-hypertension. Blood Pressure. 1996;5(1):16-26. 
  Reason for exclusion: No Sodium intervention; Study duration less than 4 weeks 
Ferri C, Bellini C, Carlomagno A, Perrone A, Santucci A. Urinary kallikrein and salt sensitivity in 
 essential hypertensive males. Kidney Int. 1994;46(3):780-8. 
  Reason for exclusion: Studies on hypertensives; Study duration less than 4 weeks 
Ferri C, Bellini C, Desideri G, Di Francesco L, De Mattia G, Santucci A, et al. Salt-sensitivity is 
 associated with a hyperinsulinaemic and hyperglycaemic response to atrial natriuretic 
 peptide infusion in human essential hypertension. Diabetologia. 1994;37(3):308-12. 
  Reason for exclusion: No intervention of interest 
Ferri C, Di Francesco L, Baldoncini R, Bellini C, Desideri G, Carlomagno A, et al. Sodium-modulating 
 hormones and the pressor response to sodium chloride in essential arterial hypertension. 
 Annali italiani di medicina interna. 1993;8(2):89-94. 
  Reason for exclusion: Studies on hypertensives; Study duration less than 4 weeks 
Fodor JG, Whitmore B, Leenen F, Larochelle P. Lifestyle modifications to prevent and control 
 hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, 
 Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for 
 Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ. 
 1999;160(9 Suppl):S29-34. 
  Reason for exclusion: Not an RCT (Review) 
Foo M, Denver AE, Coppack SW, Yudkin JS. Effect of salt-loading on blood pressure, insulin 
 sensitivity and limb blood flow in normal subjects. Clin Sci. 1998;95(2):157-64. 
  Reason for exclusion: Study duration less than 4 weeks 
Forrester T, Adeyemo A, Soarres-Wynter S, Sargent L, Bennett F, Wilks R, et al. A randomized trial 
 on sodium reduction in two developing countries. J Hum Hypertens. 2005;19(1):55-60. 
  Reason for exclusion: Study duration less than 4 weeks (3 weeks) 
Fotherby MD, Potter JF. Effects of moderate sodium restriction on clinic and twenty-four-hour 
 ambulatory blood pressure in elderly hypertensive subjects. J Hypertens. 1993;11(6):657-63. 
  Reason for exclusion: Studies on hypertensives 
Fuchs FD, Wannmacher CM, Wannmacher L, Guimaraes FS, Rosito GA, Gastaldo G, et al. Effect of 
 sodium intake on blood pressure, serum levels and renal excretion of sodium and potassium 
 in normotensives with and without familial predisposition to hypertension. Brazi J  Med Biol 
 Res.1987;20(1):25-34. 
  Reason for exclusion: Study duration less than 4 weeks 
Galley HF, Thornton J, Howdle PD, Walker BE, Webster NR. Combination oral antioxidant 
 supplementation reduces blood pressure. Clin Sci. 1997;92(4):361-5. 
  Reason for exclusion: No intervention of interest 
Garcia-Pena C, Thorogood M, Armstrong B, Reyes-Frausto S, Munoz O. Pragmatic 
randomized trial of home visits by a nurse to elderly people with hypertension in Mexico. Int J 
Epidemiol. 2001;30(6):1485-91. 
Reason for exclusion: Studies on hypertensives 
Garg SK, Gupta U, Mathur VS. Comparative bioequivalence study of furosemide in human 
 volunteers. Int J Clin Pharmacol Ther Toxicol. 1984;22(11):618-20. 
  Reason for exclusion: Participants on antihypertensive medications 
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Gates PE, Tanaka H, Hiatt WR, Seals DR. Dietary sodium restriction rapidly improves large elastic 
 artery compliance in older adults with systolic hypertension. Hypertension. 2004;44(1):35-41. 
  Reason for exclusion: Recruited above 140mmHg (indicated from baseline measurement) 
Georg Jensen M, Kristensen M, Belza A, Knudsen JC, Astrup A. Acute effect of alginate-based 
 preload on satiety feelings, energy intake, and gastric emptying rate in healthy subjects. 
 Obesity. 2012;20(9):1851-8.  
  Reason for exclusion: No intervention of interest 
Gijsbers L, Dower JI, Mensink M, Siebelink E, Bakker SJL, & Geleijnse JM. Effects of sodium and  
potassium supplementation on blood pressure and arterial stiffness: a fully controlled dietary 
 intervention study. J Hum Hypertens 2015; epub ahead of print.    
Reason for exclusion: Concomitant intervention (Potassium supplement) 
 
Glanzer K, Schlebusch H, Sorger M, Pannenbecker D, Kruck F. Influence of intravenous Mg++ 
 solutions on renal excretion of potassium, sodium, calcium, chloride, intraleukocytic 
 potassium and peripheral vascular resistance: a metabolic and hemodynamic study in 
 normal volunteers. Magnesium. 1984;3(4-6):324-38. 
  Reason for exclusion: Study duration less than 4 weeks 
Gogtay NJ, Dalvi SS, Mhatre RB, Kirodian BG, Gupta AH, Jadhav SP, et al. A randomized, crossover, 
 assessor-blind study of the bioequivalence of a single oral dose of 200 mg of four 
 formulations of phenytoin sodium in healthy, normal Indian volunteers. Ther Drug Monit. 
 2003;25(2):215-20. 
  Reason for exclusion: No intervention of interest 
 
Gomez-Marin O, Prineas RJ, Sinaiko AR. The Sodium-Potassium Blood Pressure Trial in Children. 
 Design, recruitment, and randomization: the children and adolescent blood pressure 
 program. Controlled Clin Trials. 1991;12(3):408-23. 
  Reason for exclusion: Study on paediatrics  
Gomi T, Shibuya Y, Sakurai J, Hirawa N, Hasegawa K, Ikeda T. Strict dietary sodium reduction 
 worsens insulin sensitivity by increasing sympathetic nervous activity in patients with primary 
 hypertension. Am J Hypertens. 1998;11(9):1048-55. 
  Reason for exclusion: Studies on hypertensives; Study duration less than 4 weeks 
Granero R, Linfa-Homes G, Isaacura-Lopez C, Goyo A, Flores-Finizola A, Sira A. [Clinical trial 
 withsodium fluvastatin in patients with hypercholesterolemia associated with mild and 
 moderate essential arterial hypertension]. Investigacion clinica. 1997;38(2):63-72. 
  Reason for exclusion: No Sodium intervention; Treated with statins 
Grey A, Braatvedt G, Holdaway I. Moderate dietary salt restriction does not alter insulin resistance or 
 serum lipids in normal men. Am J Hypertens. 1996;9(4 Pt 1):317-22. 
  Reason for exclusion: Study duration less than 4 weeks 
Grobbee DE, Hofman A, Roelandt JT, Boomsma F, Schalekamp MA, Valkenburg HA. Sodium 
 restriction and potassium supplementation in young people with mildly elevated blood 
 pressure. J Hypertens. 1987;5(1):115-9. 
  Reason for exclusion: Studies on children and adolescents 
China Salt Substitute Study Collaborative Group. Salt substitution: a low-cost strategy for blood 
 pressure control among rural Chinese. A randomized, controlled trial. J Hypertens. 
 2007;25(10):2011-8. 
  Reason for exclusion: Recruited above 140mmHg (mean 159mmHg) 
He FJ, Markandu ND, MacGregor GA. Importance of the renin system for determining blood pressure 
 fall with acute salt restriction in hypertensive and normotensive whites. Hypertension. 
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 2001;38(3):321-5. 
  Reason for exclusion: Study duration less than 4 weeks 
Heagerty AM, Alton SM, el-Ashry A, Bing RF, Thurston H, Swales JD. Effects of changes in sodium 
 balance on leucocyte sodium transport: qualitative differences in normotensive offspring of 
 hypertensives and matched controls. J Hypertens. 1986;4(3):333-7. 
  Reason for exclusion: No intervention of interest 
Heagerty AM, Ollerenshaw JD, Robertson DI, Bing RF, Swales JD. Influence of dietary linoleic acid 
 on leucocyte sodium transport and blood pressure. BMJ. 1986;293(6542):295-7. 
  Reason for exclusion: Study duration less than 4 weeks 
Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Burke V, Croft KD, et al. Effects of isoflavonoids on blood 
 pressure in subjects with high-normal ambulatory blood pressure levels: a randomized 
 controlled trial. Am J Hypertens. 1999;12(1 Pt 1):47-53. 
  Reason for exclusion: No intervention of interest 
Hofman A, Hazebroek A, Valkenburg HA. A randomized trial of sodium intake and blood pressure in 
 newborn infants. JAMA. 1983;250(3):370-3. 
  Reason for exclusion: Study on infants 
Hu G, Tian H. A comparison of dietary and non-dietary factors of hypertension and normal blood 
 pressure in a Chinese population. J Hum Hypertens. 2001;15(7):487-93. 
  Reason for exclusion: Not an RCT (Cross sectional) 
Huledal G, Jonzon B, Malmenas M, Hedman A, Andersson LI, Odlind B, et al. Renal effects of the 
 cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and 
 naproxen during normal and low sodium intake. Clin Pharmacol Ther. 2005;77(5):437-50. 
  Reason for exclusion: Blood pressure not measured 
 
Hunt PJ, Espiner EA, Richards AM, Yandle TG, Frampton C, Nicholls MG. Interactions of atrial and 
 brain natriuretic peptides at pathophysiological levels in normal men. Am J Physiol.  
 1995;269(6):R1397-403. 
  Reason for exclusion: No Sodium intervention; ANP infused in subjects 
 
Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three-year effects 
 of dietary changes on blood pressure. Arch Internal Med. 1990;150(1):153-62. 
  Reason for exclusion: 5% subjects baseline SBP>140mmHg. 
Ishimitsu T, Nishikimi T, Matsuoka H, Kangawa K, Kitamura K, Minami J, et al. Behaviour of 
 adrenomedullin during acute and chronic salt loading in normotensive and hypertensive 
 subjects. Clin Sci. 1996;91(3):293-8. 
  Reason for exclusion: Study duration less than 4 weeks 
Jablonski KL, Fedorova OV, Racine ML, Geolfos CJ, Gates PE, Chonchol M, et al. Dietary sodium 
 restriction and association with urinary marinobufagenin, blood pressure, and aortic 
 stiffness. CJASN. 2013;8(11):1952-9. 
  Reason for exclusion: Recruited above 140mmHg (<159mmHg) 
Jablonski KL, Racine ML, Geolfos CJ, Gates PE, Chonchol M, McQueen MB, et al. Dietary sodium 
 restriction reverses vascular endothelial dysfunction in middle-aged/older adults with 
 moderately elevated systolic blood pressure. J Am Coll Cardiol. 2013;61(3):335-43. 
  Reason for exclusion: Recruited above 140mmHg 
Jeffery RW, Pirie PL, Elmer PJ, Bjornson-Benson WM, Mullenbach VA, Kurth CL, et al. Low-sodium, 
 high-potassium diet: feasibility and acceptability in a normotensive population. Am J Public  
Health. 1984;74(5):492-4. 
  Reason for exclusion: Pilot study; no blood pressure results 
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Jern S, Wall U, Bergbrant A, Selin-Sjogren L, Jern C. Endothelium-dependent vasodilation and tissue-
 type plasminogen activator release in borderline hypertension. Arterioscler Thromb Vasc Biol.  
1997;17(12):3376-83.  
  Reason for exclusion: No Sodium intervention; Studies on hypertensives 
Johnson AG, Nguyen TV, Davis D. Blood pressure is linked to salt intake and modulated by the 
 angiotensinogen gene in normotensive and hypertensive elderly subjects. J Hypertens. 
 2001;19(6):1053-60. 
  Reason for exclusion: Recruited above 140mmHg (<160mmHg) 
Kammerer-Doak DN, Rogers RG, Johnson Maybach J, Traynor Mickelson M. Vasopressin as an 
 etiologic factor for infection in gynecologic surgery: a randomized double-blind placebo-
 controlled trial. Am J Obstet Gynecol. 2001;185(6):1344-7. 
  Reason for exclusion: No intervention of interest 
Kennon B, Ingram MC, Friel EC, Anderson NH, MacKenzie SM, Davies E, et al. Aldosterone synthase 
 gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in 
 normal male subjects. Clin Endocrinol. 2004;61(2):174-81. 
  Reason for exclusion: No intervention of interest 
Khaw KT, Thom S. Randomised double-blind cross-over trial of potassium on blood-pressure in 
 normal subjects. Lancet. 1982;2(8308):1127-9. 
  Reason for exclusion: No sodium intervention; potassium intervention only 
Kingwell BA, Jennings GL. Effects of walking and other exercise programs upon blood pressure in 
 normal subjects. MJA. 1993;158(4):234-8. 
  Reason for exclusion: No intervention of interest 
Kiowski W, Linder L, Kleinbloesem C, van Brummelen P, Buhler FR. Blood pressure control by the 
 renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting 
 enzyme and renin inhibition. Circulation. 1992;85(1):1-8. 
  Reason for exclusion: No intervention of interest 
Kisioglu AN, Aslan B, Ozturk M, Aykut M, Ilhan I. Improving control of high blood pressure among 
 middle-aged Turkish women of low socio-economic status through public health training. 
 Croat Med J. 2004;45(4):477-82. 
  Reason for exclusion: Normotension defined >140mmHg 
Klein H, Abassi Z, Keiser HR. Effects of angiotensin II and phenylephrine on urinary endothelin in 
 normal female volunteers. Metabolism. 1995;44(1):115-8.  
Reason for exclusion: No intervention of interest 
Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Low sodium diet and pregnancy-induced 
 hypertension: a multi-centre randomised controlled trial. Brit J Obstet Gynaec. 
 1998;105(4):430-4.  
  Reason for exclusion: Study on pregnant women; only diastolic inclusion 
 
Konishi Y, Okada N, Okamura M, Morikawa T, Okumura M, Yoshioka K, et al. Sodium sensitivity of 
 blood pressure appearing before hypertension and related to histological damage in 
 immunoglobulin a nephropathy. Hypertension. 2001;38(1):81-5.   
 Reason for exclusion: Participants with renal deficiency 
Kostis JB, Wilson AC, Hooper WC, Harrison KW, Philipp CS, Appel LJ, et al. Association of 
 angiotensin-converting enzyme DD genotype with blood pressure sensitivity to weight loss. 
 Am Heart J. 2002;144(4):625-9.       
Reason for exclusion: Studies on hypertensives 
Kreutz R, Kruse HJ, Overlack A, Stumpe KO, Kolloch RE. Effects of sympathetic inhibition on blood 
 pressure and renal responses to central hypervolaemia in normal humans. Acta physiologica 
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 Scandinavica. 1996;156(1):1-7.       
 Reason for exclusion: No intervention of interest 
Krishna GG, Miller E, Kapoor S. Increased blood pressure during potassium depletion in 
 normotensive men. N Eng J Med. 1989;320(18):1177-82.  
Reason for exclusion: No intervention of interest 
Kuroda S, Uzu T, Fujii T, Nishimura M, Nakamura S, Inenaga T, et al. Role of insulin resistance in the
 genesis of sodium sensitivity in essential hypertension. J Hum Hypertens. 1999;13(4):257-2. 
  Reason for exclusion: Study duration less than 4 weeks; Studies on hypertensives 
Kweon TD, Kim SH, Oh YJ, Shim JK, Hong YW, Kwak YL. Topical lidocaine effectively reduced the 
 increase of systolic blood pressure after side-clamping of the aorta in off-pump cardiac 
 surgery. Acta Anaesthesiologica Scandinavica. 2006;50(10):1218-22.  
 Reason for exclusion: Study on participants post-surgery 
Laffer CL, Elijovich F. Essential hypertension of Caribbean Hispanics: sodium, renin, and response to 
 therapy. J Clin Hypertens. 2002;4(4):266-73.  
Reason for exclusion: Recruited above 140mmHg 
Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG. Hemodynamic,  
 hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. The 
 J Clin Endocrinol Metab. 2000;85(3):1016-20.   
Reason for exclusion: Study duration less than 4 weeks 
Langrish JP, Unosson J, Bosson J, Barath S, Muala A, Blackwell S, et al. Altered nitric oxide 
 bioavailability contributes to diesel exhaust inhalation-induced cardiovascular dysfunction in 
 man. JAHA. 2013;2(1):e004309.  
Reason for exclusion: No intervention of interest 
Larson A, Witman MA, Guo Y, Ives S, Richardson RS, Bruno RS, et al. Acute, quercetin-induced 
 reductions in blood pressure in hypertensive individuals are not secondary to lower plasma 
 angiotensin-converting enzyme activity or endothelin-1: nitric oxide. Nutr Res.  
 2012;32(8):557-64. 
  Reason for exclusion: Study duration less than 4 weeks 
 
Larson C, Vaidya A, Sun B, Williams JS. Influence of dietary sodium modulation on 
 electrocardiographic voltage criteria for left ventricular hypertrophy in normotensive 
 individuals. J Invest Med. 2012;60(1):39-43.      
Reason for exclusion: Participants treated with anti-hypertensives 
Lasser VI, Raczynski JM, Stevens VJ, Mattfeldt-Beman MK, Kumanyika S, Evans M, et al. Trials of 
 Hypertension Prevention, phase II. Structure and content of the weight loss and dietary 
 sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative 
 Research Group. Ann Epidemiol. 1995;5(2):156-64. 
  Reason for exclusion: Study report of TOHP II 
Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III--
 Analysis of data from trials of salt reduction. BMJ (Clinical research ed). 1991;302(6780):819-
 24. 
  Reason for exclusion: Not an RCT (Review) 
Lawton WJ, Sinkey CA, Fitz AE, Mark AL. Dietary salt produces abnormal renal vasoconstrictor 
 responses to upright posture in borderline hypertensive subjects. Hypertension. 1988;11(6 Pt 
 1):529-36. 
  Reason for exclusion: Study duration less than 4 weeks 
Lee CY, Chen HH, Lisy O, Swan S, Cannon C, Lieu HD, et al. Pharmacodynamics of a novel 
 designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects. 
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 Journal of clinical pharmacology. 2009;49(6):668-73.     
 Reason for exclusion: Wrong style intervention; drug infusions 
Lennon-Edwards, S., Ramick, M. G., Matthews, E. L., Brian, M. S., Farquhar, W. B., & Edwards, D. G.  
Salt loading has a more deleterious effect on flow-mediated dilation in salt-resistant men than 
women. Nutr, Metab and Cardiovasc, 2014;24(9):990-995.  
Reason for exclusion: Study duration less than 4 weeks 
 
Li N, Prescott J, Wu Y, Barzi F, Yu X, Zhao L, et al. The effects of a reduced-sodium, high-potassium 
 salt substitute on food taste and acceptability in rural northern China. Brit J Nutr. 
 2009;101(7):1088-93.         
 Reason for exclusion: Not RCT; Studies on hypertensives 
 
Light RW, Peng MJ, Stansbury DW, Sassoon CS, Despars JA, Mahutte CK. Effects of sodium 
 bicarbonate administration on the exercise tolerance of normal subjects breathing through 
 dead space. Chest. 1999;115(1):102-8. 
  Reason for exclusion: Not intervention of interest 
Lijnen P, Petrov V. Dietary calcium, blood pressure and cell membrane cation transport systems in 
 males. J Hypertens. 1995;13(8):875-82. 
  Reason for exclusion: Not intervention of interest 
Lind L, Lithell H, Pollare T, Ljunghall S. Blood pressure response during long-term treatment with 
 magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in 
 essential hypertension and in subjects with high-normal blood pressure. Am J Hypertens. 
 1991;4(8):674-9. 
  Reason for exclusion: Not intervention of interest 
Little P, Girling G, Hasler A, Trafford A. A controlled trial of a low sodium, low fat, high fibre diet in 
 treated hypertensive patients: effect on antihypertensive drug requirement in clinical 
 practice. J Hum Hypertens. 1991;5(3):175-81. 
  Reason for exclusion: Studies on hypertensives 
Locatelli F, Andrulli S, Di Filippo S, Pozzoli U, Tetta C. Effect of sodium pool changes on blood 
 pressure in patients undergoing PFD: design of a prospective randomized multicenter trial. 
 J Nephrol. 2001;14(3):157-61. 
  Reason for exclusion: Participants with renal deficiency 
Lucas SJ, Tzeng YC, Galvin SD, Thomas KN, Ogoh S, Ainslie PN. Influence of changes in blood 
 pressure on cerebral perfusion and oxygenation. Hypertension. 2010;55(3):698-705. 
 Reason for exclusion: Not intervention of interest 
Luft FC, Zemel MB, Sowers JA, Fineberg NS, Weinberger MH. Sodium bicarbonate and sodium 
 chloride: effects on blood pressure and electrolyte homeostasis in normal and hypertensive 
 man. J Hypertens. 1990;8(7):663-70.  
  Reason for exclusion: Study duration less than 4 weeks 
Luther, J. M., Byrne, L. M., Yu, C., Wang, T. J., & Brown, N. J. Dietary sodium restriction decreases 
insulin secretion without affecting insulin sensitivity in humans. J Clin Endocrinol Metab. 
2014;99(10):E1895-1902. 
Reason for exclusion: Concomitant intervention  
 
MacIver DH, McNally PG, Ollerenshaw JD, Sheldon TA, Heagerty AM. The effect of short chain fatty 
 acid supplementation on membrane electrolyte transport and blood pressure. J Hum 
 Hypertens. 1990;4(5):485-90. 
  Reason for exclusion: Not intervention of interest 
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Makela P, Vahlberg T, Kantola I, Vesalainen R, Jula A. The effects of a 6-month sodium restriction on 
 cardiac autonomic function in patients with mild to moderate essential hypertension. Am J 
 Hypertens. 2008;21(11):1183-7. 
  Reason for exclusion: Studies on hypertensives 
McCarron DA. The dietary guideline for sodium: should we shake it up? Yes! Am J Clin Nutr.  
2000;71(5):1013-9. 
  Reason for exclusion: Not an RCT (Viewpoint) 
 
McCarron DA, Morris CD. Blood pressure response to oral calcium in persons with mild to moderate 
 hypertension. A randomized, double-blind, placebo-controlled, crossover trial. Ann
 Intern Med. 1985;103(6 Pt 1):825-31. 
  Reason for exclusion: Not intervention of interest 
McDonald AM, Dyer AR, Liu K, Stamler R, Gosch FC, Grimm R, et al. Sodium, lithium-
 countertransport and blood pressure control by nutritional intervention in 'mild' 
 hypertension. J Hypertens. 1988;6(4):283-91. 
  Reason for exclusion: Studies on hypertensives 
McDonald AM, Liao YL, Trevisan M, Dyer A, Gosch FC, Stamler R, et al. Sodium-lithium 
 countertransport and systolic blood pressure response to exercise. J Hypertens. 
 1990;8(2):129-37. 
  Reason for exclusion: Not intervention of interest 
Millar JA, Isles CG, Lever AF. Blood pressure, 'white-coat' pressor responses and cardiovascular risk 
 in placebo-group patients of the MRC Mild Hypertension trial. J Hypertens. 1995;13(2):175-
 83. 
  Reason for exclusion: Studies on hypertensives 
Miller SB, Friese M, Sita A. Parental history of hypertension, sodium loading, and cardiovascular 
 response to stress. Psychosom Med. 1995;57(4):381-9.    
Reason for exclusion: Study duration less than 4 weeks 
Mills PJ, Dimsdale JE, Ziegler MG, Hauger RL, Nelesen RA, Brown MR. Sympathetic alterations after 
 sodium restriction and short-term captopril administration. J Am Coll Cardiol. 1993;21(1):177-
 81. 
  Reason for exclusion: Studies on hypertensives 
Miura K, Myogadani H, Kadoya Y, Hayashi M, Motoya M, Kuzumaki M, et al. Effectiveness of lifestyle 
 modification programs for control of blood pressure: a non-randomized controlled trial in 
 Komatsu, Japan. Japanese Journal of Public Health. 2006;53(8):533-42. 
  Reason for exclusion: Recruited above 140mmHg 
Morgan T, Myers J, Teow BH. The role of sodium and potassium in the control of blood pressure. 
 Aust N Z J Med. 1984;14(4):458-62.  
Reason for exclusion: Study duration less than 4 weeks 
Moulin B, Fillastre JP, Godin M, Coquerel A, Decoopman E. Renal hemodynamics and sodium 
 excretion after acute and chronic administration of cicletanine in normotensive and 
 hypertensive subjects. J Cardiovasc Pharmacol. 1995;25(2):292-9.  
Reason for exclusion: Participants treated with anti-hypertensives (diuretics) 
Moutquin J-M, Garner PR, Burrows RF, Rey E, Helewa ME, Lange IR, et al. Report of the Canadian 
 Hypertension Society Consensus Conference: 2. Nonpharmacologic management and 
 prevention of hypertensive disorders in pregnancy. Can Med Assoc J. 1997;157(7):907-19. 
  Reason for exclusion: Not an RCT (Consensus report) 
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Mtabaji JP, Nara Y, Yamori Y. The cardiac study in Tanzania: salt intake in the causation and 
 treatment of hypertension. J Hum Hypertens. 1990;4(2):80-1.   
 Reason for exclusion: Study duration less than 4 weeks 
Myers JB, Morgan TO. Effect of alteration in sodium chloride intake on blood pressure of 
 normotensive subjects. J Cardiovasc Pharmacol. 1984;6(Suppl 1):S204-9.  
Reason for exclusion: Study duration less than 4 weeks 
Nestel PJ, Clifton PM, Noakes M, McArthur R, Howe PR. Enhanced blood pressure response to 
 dietary salt in elderly women, especially those with small waist: hip ratio. J Hypertens.  
1993;11(12):1387-94. 
  Reason for exclusion: No information on inclusion SBP (authors could not confirm) 
Nielsen OM, Engell HC. Effects of maintaining normal plasma colloid osmotic pressure on renal 
 function and excretion of sodium and water after major surgery. A randomized study. Danish 
 Medical Bulletin. 1985;32(3):182-5. 
  Reason for exclusion: Participants with renal deficiency 
Nowson C, Morgan T. Effect of calcium carbonate on blood pressure in normotensive and 
 hypertensive people. Hypertension. 1989;13(6 Pt 1):630-9.   
 Reason for exclusion: Not intervention of interest 
Nowson CA, Wattanapenpaiboon N, Pachett A. Low-sodium Dietary Approaches to Stop 
 Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal 
 women. Nutr Res. 2009;29(1):8-18.      
Reason for exclusion: Recruited above 140mmHg (<160mmHg) 
Nowson CA, Worsley A, Margerison C, Jorna MK, Frame AG, Torres SJ, et al. Blood pressure 
 response to dietary modifications in free-living individuals. J Nutr. 2004;134(9):2322-9. 
  Reason for exclusion: No SBP cut off for healthy free living individuals.  
Olsen NV, Olsen MH, Bonde J, Kanstrup IL, Plum I, Strandgaard S, et al. Dopamine natriuresis in 
 salt-repleted, water-loaded humans: a dose-response study. Brit J Clin Pharmacol. 
 1997;43(5):509-20. 
  Reason for exclusion: Wrong style sodium intervention; Drugs used 
 
Overlack A, Ruppert M, Kolloch R, Gobel B, Kraft K, Diehl J, et al. Divergent hemodynamic and 
 hormonal responses to varying salt intake in normotensive subjects. Hypertension. 
 1993;22(3):331-8. 
  Reason for exclusion: Study duration less than 4 weeks 
Pagano E, Siani A, Pauciullo P, Lirato C, Iacone R, Sacchi A, et al. Effect of dietary versus 
 pharmacological correction of hypertriglyceridemia on red blood cell membrane 
 sodium/lithium countertransport activity. Life Sciences. 1997;60(26):2389-97 
 Reason for exclusion: Recruited above 140mmHg (<160mmHg) 
Palmer RM, Osterweil D, Loon-Lustig G, Stern N. The effect of dietary salt ingestion on blood 
 pressure of old-old subjects. A double-blind, placebo-controlled, crossover trial. J Ams Geriatr  
Soc. 1989;37(10):931-6.     
Reason for exclusion: Recruited above 140mmHg 
Parker M, Puddey IB, Beilin LJ, Vandongen R. Two-way factorial study of alcohol and salt restriction 
 in treated hypertensive men. Hypertension. 1990;16(4):398-406.   
 Reason for exclusion: Participants all on anti-hypertensives 
Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet compared with low-
 sodium diet in compensated congestive heart failure: is sodium an old enemy or a new 
 friend? Clin Sci. 2008;114(3):221-30.   
Reason for exclusion: Studies on Heart failure patients 
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Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, et al. Medium term effects of 
 different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical 
 outcome in patients with recently compensated heart failure. Am J Cardiol. 2009;103(1):93-
 102. 
  Reason for exclusion: Participants all on anti-hypertensives 
 
Pechere-Bertschi A, Maillard M, Stalder H, Brunner HR, Burnier M. Blood pressure and renal 
 haemodynamic response to salt during the normal menstrual cycle. Clin Sci. 2000;98(6):697-
 702. 
  Reason for exclusion: Study duration less than 4 weeks 
 
Pedersen KE, Jest P, Klitgaard NA, Rokkedal Nielsen J, Johansen T. Effect of oral salt loading on 
 blood pressure and lymphocyte sodium metabolism in borderline hypertension. Acta medica 
 Scandinavica Supplementum. 1986;220(S714):81-5. 
  Reason for exclusion: No intervention of interest 
Phillips EM, Butler T, Baylis PH. Osmoregulation of vasopressin and thirst: comparison of 20% 
 mannitol with 5% saline as osmotic stimulants in healthy man. Clin Endocrinol. 
 1994;41(2):207-12. 
  Reason for exclusion: No intervention of interest 
Piccirillo G, Fimognari FL, Munizzi MR, Bucca C, Cacciafesta M, Marigliano V. Age-dependent 
 influence on heart rate variability in salt-sensitive hypertensive subjects. J Ams Geriatr Soc.  
1996;44(5):530-8. 
  Reason for exclusion: Study duration less than 4 weeks 
Pratt JH, Eckert GJ, Newman S, Ambrosius WT. Blood pressure responses to small doses of 
 amiloride and spironolactone in normotensive subjects. Hypertension. 2001;38(5):1124-9. 
  Reason for exclusion: Studies on hypertensives; anti-hypertensives 
Pretorius MM, Gainer JV, Van Guilder GP, Coelho EB, Luther JM, Fong P, et al. The bradykinin type 
 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular 
 resistance. Clinical Pharmacol Ther. 2008;83(1):122-9.   
Reason for exclusion: No intervention of interest 
Puska P, Iacono JM, Nissinen A, Korhonen HJ, Vartianinen E, Pietinen P, et al. Controlled, 
 randomised trial of the effect of dietary fat on blood pressure. Lancet. 1983;1(8314-5):1-5.
 Reason for exclusion: Studies in hypertensives. 
Rankin LI, Luft FC, Henry DP, Gibbs PS, Weinberger MH. Sodium intake alters the effects of 
 norepinephrine on blood pressure. Hypertension. 1981;3(6):650-6.  
 Reason for exclusion: Study duration less than 4 weeks 
Rebello T, Hodges RE, Smith JL. Short-term effects of various sugars on antinatriuresis and blood 
 pressure changes in normotensive young men. Am J Clin Nutr. 1983;38(1):84-94.
 Reason for exclusion: No intervention of interest 
Resnick LM, Catanzaro D, Sealey JE, Laragh JH. Acute vascular effects of the angiotensin II receptor 
 antagonist olmesartan in normal subjects: relation to the renin-aldosterone system. Am J 
 Hypertens. 2004;17(3):203-8. 
  Reason for exclusion: Wrong intervention; Drugs used 
Resnick LM, Lewanczuk RZ, Laragh JH, Pang PK. Parathyroid hypertensive factor-like activity in 
 human essential hypertension: relationship to plasma renin activity and dietary salt 
 sensitivity. J Hypertens. 1993;11(11):1235-41. 
  Reason for exclusion: Only Hypertensive participants received sodium intervention 
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Resnick LM, Oparil S, Chait A, Haynes RB, Kris-Etherton P, Stern JS, et al. Factors affecting blood 
 pressure responses to diet: the Vanguard study. Am J Hypertens. 2000;13(9):956-65.
 Reason for exclusion: No intervention of interest 
Ribstein J, Picard A, Armagnac C, Sissmann J, Mimran A. Inhibition of the acute effects of 
 angiotensin II by the receptor antagonist irbesartan in normotensive men. J Cardiovasc  
Pharmacol. 2001;37(4):449-60. 
  Reason for exclusion: Wrong intervention; Drugs used 
Richards AM, Tonolo G, Cleland JG, McIntyre GD, Leckie BJ, Dargie HJ, et al. Plasma atrial 
 natriuretic peptide concentrations during exercise in sodium replete and deplete normal man. 
 Clin Sci. 1987;72(2):159-64.     
Reason for exclusion: Study duration less than 4 weeks 
Rouse IL, Beilin LJ, Armstrong BK, Vandongen R. Blood-pressure-lowering effect of a vegetarian diet: 
 controlled trial in normotensive subjects. Lancet. 1983;1(8314-5):5-10.  
 Reason for exclusion: No Sodium intervention; Study duration less than 4 weeks 
Ruppert M, Diehl J, Kolloch R, Overlack A, Kraft K, Gobel B, et al. Short-term dietary sodium 
 restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive 
 adults. Klinische Wochenschrift. 1991;69(Suppl 25):51-7.   
 Reason for exclusion: Study duration less than 4 weeks 
Ruppert M, Overlack A, Kolloch R, Kraft K, Lennarz M, Stumpe KO. Effects of severe and moderate 
 salt restriction on serum lipids in nonobese normotensive adults. Am J Med Sci. 1994;307 
 (Suppl 1):S87-90. 
  Reason for exclusion: Study duration less than 4 weeks 
 
Sagnella GA, Markandu ND, Buckley MG, Miller MA, Blackwood A, Singer DR, et al. Hormonal and 
 renal responses to neutral endopeptidase inhibition in normal humans on a low and on a  high 
 sodium intake. Eur J Clin Invest. 1995;25(3):165-70.   
Reason for exclusion: Wrong style intervention; drug treatment  
Sagnella GA, Markandu ND, Buckley MG, Singer DR, MacGregor GA. Atrial natriuretic peptide-cyclic 
 GMP relationships in normal humans: effects of dietary sodium intake. Clin Sci. 
 1993;85(1):13-7. 
  Reason for exclusion: Study duration less than 4 weeks 
 
Sano J, Ohki K, Higuchi T, Aihara K, Mizuno S, Kajimoto O, et al. Effect of casein hydrolysate, 
 prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood 
 pressure or mild hypertension. Journal of Medicinal Food. 2005;8(4):423-30. 
 Reason for exclusion: Not intervetion of interest. 
Santos A, Martins MJ, Guimaraes JT, Severo M, Azevedo I. Sodium-rich carbonated natural mineral 
 water ingestion and blood pressure. Revista portuguesa de cardiologia: orgao oficial da 
 Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal 
 of the Portuguese Society of Cardiology. 2010;29(2):159-72.   
 Reason for exclusion: Study excluded in quality analysis; intervention not controlled, and  
 not of an high enough intensity to see any change to blood pressure 
Sarkkinen ES, Kastarinen MJ, Niskanen TH, Karjalainen PH, Venalainen TM, Udani JK, et al. 
 Feasibility and antihypertensive effect of replacing regular salt with mineral salt -rich in 
 magnesium and potassium- in subjects with mildly elevated blood pressure. Nutrition journal. 
 2011;10:88.          
 Reason for exclusion: Inclusion SBP>140mmHg (130-159 mmHg) 
Schorr U, Beige J, Ringel J, Turan S, Kreutz R, Distler A, et al. Hpa II polymorphism of the atrial 
 natriuretic peptide gene and the blood pressure response to salt intake in normotensive 
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 men. J Hypertens. 1997;15(7):715-8. 
  Reason for exclusion: Study duration less than 4 weeks 
Schorr U, Distler A, Sharma AM. Effect of sodium chloride- and sodium bicarbonate-rich mineral 
 water on blood pressure and metabolic parameters in elderly normotensive individuals: a  
 randomized double-blind crossover trial. J Hypertens. 1996;14(1):131-5. 
  Reason for exclusion: Recruited above 140mmHg at baseline 
Schorr U, Turan S, Distler A, Sharma AM. Relationship between ambulatory and resting blood 
 pressure responses to dietary salt restriction in normotensive men. J Hypertens. 
 1997;15(8):845-9. 
  Reason for exclusion: Study duration less than 4 weeks 
Schrader J, Luders S, Kulschewski A, Hammersen F, Plate K, Berger J, et al. Morbidity and Mortality 
 After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal 
 results of a prospective randomized controlled study (MOSES). Stroke. 2005;36(6):1218- 
26.  
  Reason for exclusion: Studies on hypertensives 
Schwartz JI, Thach C, Lasseter KC, Miller J, Hreniuk D, Hilliard DA, et al. Effects of etoricoxib and 
 comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood 
 pressure, and other renal function indicators in elderly subjects consuming a controlled 
 sodium diet. J Clin Pharmacol. 2007;47(12):1521-31.    
Reason for exclusion: Study duration less than 4 weeks 
Sciarrone SE, Beilin LJ, Rouse IL, Rogers PB. A factorial study of salt restriction and a low-fat/high-
 fibre diet in hypertensive subjects. J Hypertens. 1992;10(3):287-98.  
 Reason for exclusion: Recruited above 140mmHg 
Sharma AM, Cetto C, Schorr U, Spies KP, Distler A. Renal acid-base excretion in normotensive salt-
 sensitive humans. Hypertension. 1993;22(6):884-90.    
 Reason for exclusion: Study duration less than 4 weeks 
Sharma AM, Ruland K, Spies KP, Distler A. Salt sensitivity in young normotensive subjects is 
 associated with a hyperinsulinemic response to oral glucose. J Hypertens. 1991;9(4):329-35. 
  Reason for exclusion: Study duration less than 4 weeks 
Sharma AM, Schattenfroh S, Kribben A, Distler A. Reliability of salt-sensitivity testing in normotensive 
 subjects. Klinische Wochenschrift. 1989;67(12):632-4.    
 Reason for exclusion: Study duration less than 4 weeks 
Sharma AM, Schorr U, Distler A. Insulin resistance in young salt-sensitive normotensive subjects. 
 Hypertension. 1993;21(3):273-9. 
  Reason for exclusion: Study duration less than 4 weeks 
Sharma AM, Schorr U, Oelkers W, Distler A. Effects of sodium salts on plasma renin activity and 
 norepinephrine response to orthostasis in salt-sensitive normotensive subjects. Am J 
 Hypertens. 1993;6(9):780-5. 
  Reason for exclusion: Study duration less than 4 weeks 
Siani A, Strazzullo P, Russo L, Guglielmi S, Iacoviello L, Ferrara LA, et al. Controlled trial of long term 
 oral potassium supplements in patients with mild hypertension. BMJ. 1987;294(6585):1453-6. 
  Reason for exclusion: No intervention of interest 
 
Sinaiko AR, Gomez-Marin O, Prineas RJ. Effect of low sodium diet or potassium supplementation on 
 adolescent blood pressure. Hypertension. 1993;21(6 Pt 2):989-94.  
 Reason for exclusion: Study on adolescents 
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Singh RB, Sharma VK, Rastogi SS, Singh NK. In patients with mild hypertension, does exercise and a 
 gradual rather than abrupt increase in fatty acid and salt intake cause less rise in 
 cardiovascular risk factors? Clin Nutr. 1992;11(5):309-14.  
Reason for exclusion: Studies on hypertensives 
Skrabal F, Aubock J, Hortnagl H. Low sodium/high potassium diet for prevention of hypertension: 
 probable mechanisms of action. Lancet. 1981;2(8252):895-900.   
 Reason for exclusion: Study duration less than 4 weeks 
Staessen J, Bulpitt CJ, Fagard R, Joossens JV, Lijnen P, Amery A. Salt intake and blood pressure in 
 the general population: a controlled intervention trial in two towns. J Hypertens. 
 1988;6(12):965-73. 
  Reason for exclusion: Not an RCT (cross sectional) 
Stamler J, Caggiula A, Grandits GA, Kjelsberg M, Cutler JA. Relationship to blood pressure of 
 combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention 
 Trial (MRFIT). Circulation. 1996;94(10):2417-23.     
 Reason for exclusion: Studies on participants with diabetes 
Stamler R, Grimm RH, Jr., Dyer AR, Talano JV, Prineas R, Crow R, et al. Cardiac status after four 
 years  in a trial on nutritional therapy for high blood pressure. Arch Intern Med. 
 1989;149(3):661-5. 
  Reason for exclusion: Studies on hypertensives 
Stamler R, Stamler J, Grimm R, Gosch FC, Elmer P, Dyer A, et al. Nutritional therapy for high blood 
 pressure. Final report of a four-year randomized controlled trial--the Hypertension Control 
 Program. JAMA. 1987;257(11):1484-91. 
  Reason for exclusion: Participants all on anti-hypertensives, discontinued 2 months in 
Straznicky NE, Howes LG, Barrington VE, Lam W, Louis WJ. Effects of dietary lipid modification on 
 adrenoceptor-mediated cardiovascular responsiveness and baroreflex sensitivity in 
 normotensive subjects. Blood Pressure. 1997;6(2):96-102. 
  Reason for exclusion: No Sodium intervention; Study duration less than 4 weeks 
Straznicky NE, Louis WJ, McGrade P, Howes LG. The effects of dietary lipid modification on blood 
 pressure, cardiovascular reactivity and sympathetic activity in man. J Hypertens. 
 1993;11(4):427-37. 
  Reason for exclusion: No Sodium intervention; Study duration less than 4 weeks 
Suckling RJ, He FJ, Markandu ND, MacGregor GA. Dietary salt influences postprandial lasmasodium 
 concentration and systolic blood pressure. Kidney Int. 2012;81(4):407-11. 
 Reason for exclusion: Wrong sodium type intervention (one meal) 
Sudhir K, Friberg P, Meredith IT, Woods RL, Esler MD, Jennings GL. Cardiac secretion and renal 
 clearance of atrial natriuretic peptide in normal man: effect of salt restriction. Clin Sci. 
 1989;77(6):605-10. 
  Reason for exclusion: Blood pressure not measured/reported 
Svetkey LP, Simons-Morton DG, Proschan MA, Sacks FM, Conlin PR, Harsha D, et al. Effect of the 
 dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure 
 control. J Clin Hypertens. 2004;6(7):373-81.   
Reason for exclusion: Recruited above 140mmHg 
Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA. Modest salt reduction reduces blood 
 pressure and urine protein excretion in black hypertensives: a randomized control trial. 
 Hypertension. 2005;46(2):308-12. 
  Reason for exclusion: Recruited above 140mmHg 
JBI Database of Systematic Reviews & Implementation Reports 
Page | 44  
This is a non-final, peer reviewed version of an article published in final form in: 
Kelly, J., Khalesi, S., Dickinson, K., Hines, S., Coombes, J. S., & Todd, A. S. (2016). The effect of dietary sodium modification on blood pressure in adults with 
systolic blood pressure less than 140 mmHg: A systematic review. JBI Database of Systematic Reviews and Implementation Reports, 14(6), 196-237. 
https://doi.org/10.11124/JBISRIR-2016-002410 
Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, et al. Aging and endothelial function 
 in normotensive subjects and patients with essential hypertension. Circulation. 
 1995;91(7):1981-7. 
  Reason for exclusion: Not intervention of interest 
Tarhan F, Erbay E, Eryildirim B, Faydaci G, Kuyumcuoglu U. The effect of intravesical sodium 
 nitroprusside on idiopathic detrusor overactivity. Urol Res. 2004;32(3):200-3.  
Reason for exclusion: Not intervention of interest 
Terra SG, Blum RA, Wei GC, Lew RA, Digenio AG, Rajman I, et al. Evaluation of methods for  
improving precision of blood pressure measurements in phase I clinical trials. J Clin 
Pharmacol. 2004;44(5):457-63. 
Reason for exclusion: Not intervention of interest 
Todd, A. S., MacGinley, R. J., Schollum, J. B., Johnson, R. J., Williams, S. M., Sutherland, W. H.,  
Walker, R. J. Dietary salt loading impairs arterial vascular reactivity. Am J Clin Nutr. 
2010;91(3):557-564. 
Reason for exclusion: Studies on hypertensives 
Tomita Y, Ueno M, Tsuchihashi T, Muratani H, Kobayashi K, Takishita S, et al. Chloride ion plays an 
 important role in sodium induced volume expansion in normal humans. Am J Hypertens. 
 1990;3(6 Pt 1):485-7. 
  Reason for exclusion: Study duration less than 4 weeks 
Townsend MS, Fulgoni VL, 3rd, Stern JS, Adu-Afarwuah S, McCarron DA. Low mineral intake is 
 associated with high systolic blood pressure in the Third and Fourth National Health and 
 Nutrition Examination Surveys: could we all be right? Am J Hypertens. 2005;18(2 Pt 
 1):261-9. 
  Reason for exclusion: Not RCT 
Townsend RR, Kapoor S, McFadden CB. Salt intake and insulin sensitivity in healthy human 
 volunteers. Clin Sci. 2007;113(3):141-8.   
Reason for exclusion: Study duration less than 4 weeks 
Tzemos N, Lim PO, Wong S, Struthers AD, MacDonald TM. Adverse cardiovascular effects of acute 
 salt loading in young normotensive individuals. Hypertension. 2008;51(6):1525-30.
 Reason for exclusion: Study duration less than 4 weeks 
Udelson JE, Bilsker M, Hauptman PJ, Sequeira R, Thomas I, O'Brien T, et al. A multicenter, 
 randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to 
 furosemide and the combination of tolvaptan and furosemide in patients with heart 
 failure and systolic dysfunction. J Card Fail. 2011;17(12):973-81.   
Reason for exclusion: Not intervention of interest 
Uusitupa M, Korhonen M, Litmanen H, Niskanen L, Vaisanen S, Rauramaa R. Effects of moderate 
 salt restriction alone and in combination with cilazapril on office and ambulatory blood 
 pressure. J Hum Hypertens. 1996;10(5):319-26. 
  Reason for exclusion: Recruited above 140mmHg 
van de Wal RM, Gansevoort RT, van der Harst P, Boomsma F, Thijs Plokker HW, van Veldhuisen DJ, 
 et al. Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary  
 albumin excretion in nondiabetic patients. Hypertension. 2006;48(5):870-6. 
  Reason for exclusion: No Sodium intervention; Recruited above 140mmHg 
van Paassen P, de Zeeuw D, Navis G, de Jong PE. Does the renin-angiotensin system determine the 
 renal and systemic hemodynamic response to sodium in patients with essential 
 hypertension? Hypertension. 1996;27(2):202-8. 
  Reason for exclusion: Study duration less than 4 weeks (3 weeks) 
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Vierhapper H, Waldhausl W, Nowotny P. Effect of indomethacin upon angiotensin-induced changes 
 in blood pressure and plasma aldosterone in normal man. Eur J Clin Invest. 1981;11 
(2 Suppl 1):85-9.  
  Reason for exclusion: Not intervention of interest 
Visser FW, Boonstra AH, Titia Lely A, Boomsma F, Navis G. Renal response to angiotensin II is 
 blunted  in sodium-sensitive normotensive men. Am J Hypertens. 2008;21(3):323-8. 
 Reason for exclusion: Study duration less than 4 weeks 
Volek JS, Mazzetti SA, Farquhar WB, Barnes BR, Gomez AL, Kraemer WJ. Physiological 
responses to short-term exercise in the heat after creatine loading. Med Sci Sports Exerc. 
2001;33(7):1101-8. 
Reason for exclusion: No Sodium intervention; Study duration less than 4 weeks 
Wan L, Bellomo R, May CN. A comparison of 4% succinylated gelatin solution versus normal saline in 
 stable normovolaemic sheep: global haemodynamic, regional blood flow and oxygen 
 delivery effects. Anaesth Intensive Care. 2007;35(6):924-31:85-9. 
  Reason for exclusion: Not intervention of interest 
Wan L, Bellomo R, May CN. The effects of normal and hypertonic saline on regional blood flow and 
 oxygen delivery. Anesth Analg. 2007;105(1):141-7.    
Reason for exclusion: Studies in sheep (non-human study) 
Wedler B, Brier ME, Wiersbitzky M, Gruska S, Wolf E, Kallwellis R, et al. Sodium kinetics in salt-
 sensitive and salt-resistant normotensive and hypertensive subjects. J Hypertens. 
 1992;10(7):663-9. 
  Reason for exclusion: No Sodium intervention; Study duration less than 4 weeks 
Weinberger MH, Wagner UL, Fineberg NS. The blood pressure effects of calcium supplementation in 
 humans of known sodium responsiveness. Am J Hypertens. 1993;6(9):799-805. 
  Reason for exclusion: No Sodium intervention; calcium treatment 
Weir MR, Dengel DR, Behrens MT, Goldberg AP. Salt-induced increases in systolic blood pressure 
 affect renal hemodynamics and proteinuria. Hypertension. 1995;25(6):1339-44. 
 Reason for exclusion: Study duration less than 4 weeks 
Wenner MM, Edwards DG, Ray CA, Rose WC, Gardner TJ, Stillabower M, et al. Celecoxib does not 
 alter cardiovascular and renal function during dietary salt loading. Clin Exp Pharmacol  
Physiol. 2011;38(8):543-9. 
  Reason for exclusion: Wrong intervention; drug infusions 
Whelton PK, Appel L, Charleston J, Dalcin AT, Ewart C, Fried L, et al. The effects of 
 nonpharmacologic interventions on blood pressure of persons with high normal levels: results 
 of the Trials of  Hypertension Prevention, phase I. JAMA. 1992;267(9):1213-20.  
 Reason for exclusion: Included 5% participants >140mmHg at baseline 
Whelton PK, Hebert PR, Cutler J, Applegate WB, Eberlein KA, Klag MJ, et al. Baseline characteristics 
 of participants in phase I of the Trials of Hypertension Prevention. Ann Epidemiol. 
 1992;2(3):295-310. 
  Reason for exclusion: Not RCT (report from TOHP I) 
Whelton PK, Kumanyika SK, Cook NR, Cutler JA, Borhani NO, Hennekens CH, et al. Efficacy of 
 nonpharmacologic interventions in adults with high-normal blood pressure: results from 
 phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention 
 Collaborative Research Group. Am J Clin Nutr. 1997;65(2 Suppl):652S-60S. 
  Reason for exclusion: Not RCT (report from TOHP I) 
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White WB, Derosier FJ, Thompson AH, Adams BE, Goodman DK. Evaluation of the migraine 
 treatment sumatriptan/naproxen sodium on blood pressure following long-term 
 administration. J Clin Hypertens 2011;13(12):910-6.  
Reason for exclusion: Wrong intervention; on medications 
Williamson PM, Buddle ML, Brown MA, Whitworth JA. Ambulatory blood pressure monitoring 
 (ABPM) in the normal menstrual cycle and in women using oral contraceptives. Comparison 
 with conventional blood pressure measurement. Am J Hypertens. 1996;9(10 Pt 1):953-8.
 Reason for exclusion: No Sodium intervention; women using OCP 
Wilson DK, Sica DA, Miller SB. Effects of potassium on blood pressure in salt-sensitive and salt-
 resistant black adolescents. Hypertension. 1999;34(2):181-6.   
 Reason for exclusion: Studies in adolescents; Study duration less than 4 weeks 
Wray DW, Nishiyama SK, Harris RA, Zhao J, McDaniel J, Fjeldstad AS, et al. Acute reversal of 
 endothelial dysfunction in the elderly after antioxidant consumption. Hypertension. 
 2012;59(4):818-24. 
  Reason for exclusion: Not intervention of interest 
Wright JT, Jr., Rahman M, Scarpa A, Fatholahi M, Griffin V, Jean-Baptiste R, et al. Determinants of 
 salt sensitivity in black and white normotensive and hypertensive women. Hypertension. 
 2003;42(6):1087-92. 
  Reason for exclusion: Study duration less than 4 weeks 
Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle 
 modification on blood pressure control. JAMA. 2003;289(16):2083. 
  Reason for exclusion:Statisitical data could not be provided by authors regarding non-
 hypertensive subgroup. 
Yazici M, Kaya A, Kaya Y, Albayrak S, Cinemre H, Ozhan H. Lifestyle modification decreases the 
 mean platelet volume in prehypertensive patients. Platelets. 2009;20(1):58-63. 
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Surg. 2001;71(1):138-41. 
Reason for exclusion: No Sodium intervention; participants undergoing surgery 
Zhou B, Wang HL, Wang WL, Wu XM, Fu LY, Shi JP. Long-term effects of salt substitution on blood 
 pressure in a rural north Chinese population. J Hum Hypertens. 2013;27(7):427-33. 
  Reason for exclusion: Information on SBP cut off for normotensive subpopulation could not 
 be obtained. included participants with diabtes melittus. 
Zhou, X., Liu, J.-X., Shi, R., Yang, N., Song, D.-L., Pang, W., & Li, Y.-M. Compound ion salt, a novel 
low-sodium salt substitute: from animal study to community-based population trial. Am J 
Hypertens,2009;22(9):934-942.  
Reason for exclusion: Concomitant intervention (Potassium supplement) 
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Appendix VI: Results of sensitivity analysis using alternative levels of correlation 
coefficient (r= 0.2, and 0.8) associated with flaxseed meta- analysis of the effect of salt 
modification on blood pressure and pulse wave velocity. 
 
Alternative r  Mean difference (95% 
CI), mm Hg 
p value I2 I2 of main 
analysis (with 
r=0.05) 
0.2 SBP -0.67 (-1.77, 0.43) 0.23 16% 53% 
 DBP -0.56 (-1.19, 0.07) 0.08 0% 0% 
 PWV 0.85 (-1.44, 3.13) 
 
0.47 0% 0% 
0.8 SBP -0.38 (-1.93, 1.17) 0.63 69% 53% 
 DBP -0.54 (-1.10, 0.03) 0.06 3% 0% 
 PWV 0.73 (-0.75, 2.21]) 
 
0.33 30% 0% 
Changes in SBP, DBP, and PWV are presented as mean difference and 95% CI. Heterogeneity (I2) is 
presented by %.  A p-value <0.05 was considered significant.  
 
